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1 The periodontium
The periodontium are periodontal tissues, which connect the teeth with the 
surrounding bone and support as well as maintain the teeth in the maxilla and 
mandible. The periodontium consists of four principal components, i.e. the root 
cementum, periodontal ligament (PDL), alveolar bone and gingiva, as shown in 
Figure 1[1]. In many clinical incidences, periodontal tissues can be lost or damaged 
to such extent that repair or regeneration are considered necessary. When looking 
at regeneration of periodontal tissues, it is important to understand the natural 
formation of these tissues during the developmental process. 
 
figure 1 |  The periodontium
The tooth itself is formed as a result of reciprocal interaction between the neural 
crest cell-derived ectomesenchyme (which can differentiate into the pulp, dentin, 
cementum, periodontal ligament and alveolar bone) and the dental epithelium 
(producing the dental enamel)[2,3]. Five distinct morphological stages are involved 
in dental development: respectively named the bud, cap, bell, crown, and root 
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stages (Figure 2). The beginning of the development of the tooth supporting structures, 
including periodontal ligament and alveolar bone, is around the bell stage.
figure 2 |  Tooth development
At the bell stage, the tooth germ consists of the enamel organ (which gives rise to 
ameloblasts), dental papilla (which gives rise to odontoblasts) and dental follicle 
(which gives rise to cementum, periodontal ligament and alveolar bone). Development 
of the periodontal tissues begins when epithelial cells from the cervical loop of the 
enamel organ grow apically to form the Hertwig’s epithelial root sheath (HERS)[4]. 
The HERS separates cells of the dental papilla from the dental follicle. Then, dental 
papilla cells differentiate into odontoblasts, which give rise to root dentin. In addition, 
a fine matrix of proteins (the hyaline layer of Hopewell Smith) are secreted onto the 
dentin surface by the cells of the HERS[5]. Subsequently, the disintegration of HERS 
allows ectomesenchymal cells of the dental follicle to contact with the newly formed 
protein matrix and differentiate into cementoblasts to form cementum. Part of the 
cementoblasts are entrapped within the cementum as they produce and become 
cementocytes[6]. Along with increasing cementum deposition, the root continues 
to develop apically. Meanwhile, collagen fibre bundles are embedded in the newly 
formed cementum, which are known as Sharpey’s fibres. Afterwards, fibroblasts, 
which are also derived from the dental follicle, start to form the periodontal ligament[7]. 
Also, active osteoblasts originating from the dental follicle form bundle bone. This is 
the part of the alveolar process that surrounds the teeth and into which the collagen 
fibres of the periodontal ligament are embedded. Finally, the development of the 
periodontal attachment complex is completed by the insertion of Sharpey’s fibres into 
this newly formed bone[8]. Consequently, the creation of the periodontium is the result 
of the coordinated development of cementum, periodontal ligament and alveolar 
bone, accompanied by the conversion of reduced enamel epithelium into sulcular and 
junctional epithelium during tooth eruption[9]. The next paragraphs will discuss the 
components of the periodontium in more detail. 
BUD STAGE CAP STAGE EARLY BELL STAGE LATE BELL STAGE TOOTH
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1.1 Cementum
Cementum is an avascular, bone-like connective tissue covering the entire root 
surface, and it is firmly interlocked with the dentin of the root. The cementum 
constitutes the interface between the root dentin and periodontal ligament, and 
functions as a tooth-supporting device together with the periodontal ligament fibres 
and alveolar bone. It consists of about 45% to 50% inorganic hydroxyapatite and 
50% to 55% organic matter (mainly collagen and proteoglycans) including water by 
weight. In human cementum, the only collagen type appears to be type I collagen[10], 
and the major non-collagenous proteins are bone sialoprotein and osteopontin, 
which bind collagen fibrils and hydroxyapatite respectively during the mineralization 
process. The attachment of cementum onto dentin is mainly attributed to the 
mineralization of mantle dentin, which allows the blend of collagen fibrils from dentin 
and cementum. Such mineralization spreads out from the dentin surface, through the 
dentin-cementum junction and into cementum, resulting in an amalgamated mass of 
mineral[11].
Traditionally, the cementum has been classified as cellular and acellular cementum, 
depending on the inclusion and non-inclusion of cementocytes. Further, cementum can 
be classified into intrinsic and extrinsic fibre cementum: intrinsic fibres are the fibres 
of cementum secreted by only cementoblasts; extrinsic fibres are the embedded ends 
of the principal fibres, which are secreted by fibroblasts and partly by cementoblasts. 
The first cementum to be formed during tooth development is acellular extrinsic fibre 
cementum, which contains densely packed extrinsic fibres and no cementocytes. 
This type usually covers the cervical root surface, with the extrinsic fibres obliquely 
oriented to it. Cellular cementum is mostly distributed in the furcation area and the 
apical portions of the roots, in which cementoblasts remain trapped in lacunae within 
their own matrix, very much like the osteocytes in bone. Acellular cementum anchors 
the tooth together with the principle fibres and alveolar bone, while cellular cementum 
has an adaptive function, restructuring the root surface during orthodontic tooth 
movement and compensating for crown wear[12-14].
1.2 Periodontal ligament
Periodontal ligament (PDL) is a specialized connective tissue, which is embedded 
between the root cementum and the inner wall of the alveolar bone socket. Its role 
is to maintain and support teeth in situ as well as to preserve tissue homoeostasis. 
The PDL consists of different kinds of cells and extracellular matrix. The cells include 
fibroblasts, osteoblasts and osteoclasts, epithelial cell remnants of Malassez, 
undifferentiated mesenchymal cells, cementoblasts, odontoclasts, monocytes and 
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macrophages. The extracellular matrix includes well-defined collagen fibre bundles, 
oxytalan fibres and non-collagenous extracellular matrix. The thickness of PDL ranges 
from 0.15 to 0.38 mm in humans, with its thinnest portion located in the middle third 
of the root. A progressive decrease in thickness can also be observed with growing 
age. The PDL absorbs, perceives and transfers forces between the teeth and alveolar 
bone, acting as effective support and sensor during the masticatory function. It also 
has a neuromuscular control function for mastication and the thickness of PDL can be 
adapted by as much as 50% to increased or decreased mechanical loading, without 
losing its original architecture. Additionally, the PDL is a highly vascularized tissue, 
including three principal sources of blood vessels (apical vessels, perforating vessels 
and gingival vessels), which maintain the vitality of the surrounding cells[1,7,14,15].
The PDL contains a population of multipotent postnatal stem cells, which can form 
cementum, collagen fibres and bone[16]. However, previous animal experiments 
showed that pathological removal or damage of the PDL could also result in ankylosis, 
which means that bone tissue grows into the periodontal ligament space and 
establishes a direct fusion of the tooth with the alveolar bone[17,18]. This non-resilient 
type of tooth support usually leads to loss of adaptive function of the periodontium 
and resorption of the root. In that way, the migration and eruption of the tooth are 
greatly impaired[19].
1.3 Alveolar bone
The alveolar process is the thickened ridge of bone that holds the teeth. The alveolar 
process is composed of the outer cortical plates (buccal and lingual/palatal) consisting 
of compact bone, a central mass of cancellous bone, and the bone lining the tooth 
socket (bundle bone or alveolar bone proper). The cortical plate and bone lining of 
the tooth socket emerge at the alveolar crest. Since extrinsic collagen fibre bundles 
of the periodontal ligament (Sharpey’s fibres) are embedded in the bone lining of the 
tooth socket, this bone portion is also named bundle bone. Generally, fewer intrinsic 
collagen fibres are included in bundle bone than in other types of bone[1,14,20,21].
During osteogenesis, two different mechanisms are involved in bone formation: 
intramembranous ossification and endochondral ossification. Intramembranous 
ossification mainly occurs during formation of the flat bones of the skull, but also 
the maxilla, part of mandible (including the alveolar bone) and clavicles. In this 
process, bone marrow stromal cells condense and differentiate into osteoprogenitor 
cells, some of which become more columnar and differentiate into osteoblasts. The 
osteoblasts secrete an extracellular matrix (osteoid) and are embedded therein to 
become osteocytes. Then the mineralization of osteoid results in the formation of 
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nidus (rudimentary bone tissue), which contains osteocytes in the centre and active 
osteoblasts on the edge. Conversely, endochondral ossification occurs in most bones 
of the vertebrate skeleton (e.g. long bones), parts of the mandible and also during 
the natural healing of bone fractures. In this process, bone marrow stromal cells 
experience hypoxia and differentiate into chondrogenic lineage. Chondrocytes secrete 
abundant cartilaginous matrix to form a cartilage template, and gradually differentiate 
into hypertrophic chondrocytes, during which the chondrocytes mineralize, secrete 
vascular endothelial growth factor (VEGF) and eventually become apoptotic. Then, 
osteoblasts and osteoclasts, which obtain nutrition and oxygen from the blood 
vessels, reach the mineralized matrix and promote the transformation of this cartilage 
structure into bone[22-25].
Remodelling of alveolar bone occurs during normal functioning and increased 
mechanical loading. Usually, this remodelling process is in balance, which means that 
there is an equilibrium between bone breakdown and bone deposition. Together with 
the deposition of cementum throughout life, this bone balance maintains the tissue 
homoeostasis between the root and the alveolar bone socket. In contrast, during 
orthodontic tooth movement, the PDL is compressed adjacent to the alveolar bone 
on the side toward which the force is directed, which results in bone resorption; on 
the other side, away from the force direction, the PDL is extended and new bone is 
formed[26,27]. During tooth movement, the periodontal ligament attachment is lost only 
partially and for short periods of time, and alveolar bone resorption is asynchronous.[28]
1.4 Gingiva
The gingiva is the soft tissue covering the alveolar process and which is surrounding 
the cervical portion of the teeth. The gingiva is composed of an epithelial layer and a 
connective tissue layer underneath. Anatomically, the gingiva is divided into marginal 
(free) gingiva, attached gingiva and interdental gingiva[1]. The terminal edge of gingiva 
surrounding the teeth in a collar-like fashion is called marginal gingiva. On the 
vestibular and lingual sides of the teeth, the marginal gingiva extends from the gingival 
margin in an apical direction to the sulcus, which is positioned at a level corresponding 
to the level of the cementoenamel junction (CEJ). The epithelium covering the marginal 
gingiva can be classified into three parts: i.e. the oral epithelium, which extends from 
the mucogingival junction to the gingival margin; the sulcular epithelium, which is the 
epithelium lining the gingiva within the gingival sulcus; and the junctional epithelium, 
which is attached to the tooth on one side and to the gingival connective tissue on 
the other side. The junctional epithelium serves as the special route between the 
sulcus and the connective tissue. Bacterial products from the sulcus, as well as fluid 
and cells from the connective tissue need to go through it to the other side[29]. The 
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attached gingiva is firm, resilient and tightly bound to the underlying periosteum of 
alveolar bone. It is continuous with the marginal gingival, with surface stippling on 
it. The interdental gingiva is the part of gingiva that exists between the teeth and fills 
in the gingival embrasure, which is the interproximal space beneath the area of tooth 
contact. The shape of the interdental gingiva is determined by the contact between the 
teeth, the width of the approximal tooth surface, and the course of the CEJ.
2 Periodontal disease
Periodontal disease is an inflammatory disorder of the periodontium (the tissues 
surrounding and supporting the teeth). Generally, the most common types of 
periodontal disease are gingivitis and periodontitis, which are caused by pathogenic 
microflora in the dental plaque or biofilm that forms around the teeth daily[30,31]. 
Gingivitis, as the most common and moderate form of periodontal disease, affects 50-
90% of the adult population worldwide, depending on its particular definition[32]. It is 
reversible with effective oral hygiene. However, if left untreated, gingivitis can progress 
to periodontitis, an advanced periodontal disease, in which the inflammatory and 
irreversible destruction of periodontium is involved. Periodontitis is characterized by 
the loss of the connective tissue attachment that supports the tooth (root cementum, 
periodontal ligament and alveolar bone) and the formation of a soft tissue pocket 
between the gingiva and tooth root. This often results in a functionally and aesthetically 
compromised dentition and eventually tooth loss, and has an impact on patients’ oral 
health, general nutrition intake, social activity and psycho-social well-being. Also, 
some systemic diseases and conditions are often mentioned to be associated with 
periodontitis, such as preterm birth, cardiovascular disease, stroke, diabetes and 
pulmonary disease[33,34]. Surveys have shown that approximately 46% of individuals 
at 30 years of age and older in the United States have periodontitis[35]. Between 1990 
and 2010, the global age standardized prevalence of severe periodontitis was static at 
11.2%[36].
3 Periodontal treatment
The aim of periodontal treatment is to eliminate the oral infection, arrest the 
progressive destruction of the periodontium and restore the lost periodontal tissue 
to a healthy status. However, due to the unique structure and conformation of 
the periodontium, consisting of soft and hard connective tissues and epithelium, 
periodontal healing is a very unpredictable and complex process[30,37,38]. The 
conventional clinical treatment includes non-surgical procedures, such as manual 
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and ultrasonic scaling and root planing, and surgical procedures, such as open 
flap debridement and osseous surgery. These procedures intend to remove dental 
plaque and calculus from the tooth-crown and root surface, and to smooth the root 
surface to remove bacterial toxins. Together with improved personal oral hygiene, 
supplemental use of local antimicrobials, antiseptic drugs or systemic antimicrobials, 
the tissue inflammation and pocket depth can be reduced, and the re-attachment 
of connective tissue to the root surface is promoted[39]. Consequently, a process of 
repair could be achieved through these techniques, leading to the formation of a long 
junctional epithelial attachment in the periodontal wound site. Occasionally, root 
resorption and/or ankylosis can be observed. The gingival epithelial attachment, i.e. 
the connection between connective tissue and the adjacent root surface, is relatively 
weak[40]. Along with the apical extension of the epithelium from the sulcus bottom to 
the root surface, the free surface of the epithelium increases in size. Therefore, this 
long junctional epithelial attachment is exposed to more bacterial plaque, and fluid 
flow through the junctional epithelium changes drastically[29,41]. More importantly, the 
lost alveolar bone and cementum can hardly be restored through these procedures, 
and several limitations are involved. Firstly, due to the reduction of hard supporting 
tissues, the mobility of the tooth can hardly be restored; secondly, gingival recession 
is frequently occurred after such treatment, which is both aesthetically unfavourable 
and may increase the risk of root caries; finally, it is assumed that, without restoration 
of the original periodontal structure and anatomy, the recurrence of disease in the 
periodontal site may be more susceptible in the future[42].
Therefore, for the regeneration of lost periodontium, a plethora of different techniques 
have been employed, such as guided tissue regeneration (GTR), implantation of 
different bone grafts and/or substitutes, enamel matrix derivative, growth factors 
or various combinations thereof. These techniques will be discussed in the next 
paragraphs. 
3.1 Guided Tissue Regeneration (GTR)
According to the Glossary of Periodontal Terms (4th Edition)[43], guided tissue regeneration 
is defined as follows: “Procedures attempting to regenerate lost periodontal structures 
through differential tissue responses. Guided bone regeneration typically refers to 
ridge augmentation or bone regenerative procedures; guided tissue regeneration 
typically refers to the regeneration of periodontal attachment. Barrier techniques, 
using materials such as expanded polytetrafluoroethylene, polyglactin, polylactic 
acid, calcium sulfate, and collagen, are employed in the hope of excluding epithelium 
and the gingival corium from the root or existing bone surface in the conviction that 
they interfere with regeneration.” The concept of GTR was introduced by Melcher[38], 
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who proposed the necessity of excluding undesirable cell lines from healing sites in 
order to allow growth of desired tissues. Since most types of periodontal cells migrate 
approximately 10 times slower than epithelial cells[44], a barrier should be used to 
exclude the epithelial cells from the periodontal wound site, then other cell types 
with regenerative potential can thrive. In other words, when epithelial downgrowth 
is prevented, regeneration can be achieved. Compared with open flap debridement, 
GTR possesses some greater effect on periodontal healing, such as reduced pocket 
depth, improved re-attachment of connective tissue, less gingival recession and more 
gain in hard tissue probing at re-entry surgery[45]. Currently, this technique has become 
a widely accepted clinical procedure and is the “golden standard” for periodontal 
regeneration in the clinic (Figure3)[46]. 
 
figure 3 |  Guided tissue regeneration
However, due to a lack of regenerative potential, destructed periodontal tissues are 
barely regenerated. Even using GTR, the clinical improvements are minor and highly 
variable[47]. For example, GTR has an average additional attachment gain ranging 
from 0.02 to 3.60 mm between studies compared to open flap debridement, and 
the attachment loss after GTR treatment may continue at rates from 0.1 to 3 mm per 
year[45]. This range is great and the clinical outcomes are difficult to control. Likewise, 
several decisive factors are involved in the successful application of GTR with most 
predictable clinical results: certain defect structure (e.g. two and three-wall intra-bony 
defects, class II mandibular furcation), the ‘surgeons’ experience (skills, decision-
making), certain patient characteristics (good oral hygiene, non-smokers), and the 
biocompatibility and mechanical properties of the barrier membrane[48].
3.2 Bone grafts and substitutes
Conventional surgical procedures, such as GTR or open flap debridement provide 
critical access to the root surface and establish improved periodontal healing. However, 
the regeneration of hard periodontal tissues (alveolar bone and cementum) through 
these surgical procedures is very limited. Bone replacement grafts can function as 
Periodontal
defect
Barrier
membrane Bone graft
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structural scaffolds and matrices for the attachment, proliferation and differentiation 
of osteoprogenitor cells. Therefore, a wide range of bone replacement materials, 
including bone grafts and synthetic substitutes, have been investigated to specify 
the ability to stimulate bone regeneration and promote regeneration in periodontal 
defects[49]. These include introduction of autografts (grafted tissue from one part of 
the body to another in the same individual, such as iliac cancellous bone), allografts 
(tissue between individuals of the same species but genetically non-identical, such 
as demineralized freeze-dried bone), xenografts (grafted materials between different 
species, such as bovine derived bone replacement grafts) and alloplastic materials 
(generally synthetic/semisynthetic materials, such as tricalcium phosphate, bio-
ceramics and hydroxyapatite)[50]. The use of such grafting materials with or without 
barrier membranes may result in evidence of periodontal regeneration (reduced 
crestal bone loss, increased bone level, reduced probing depth, and increased clinical 
attachment level compared to open flap debridement procedures), but the therapeutic 
effect is predominantly in bone repair[51,52]. Minimal osteoinductive and cementogenic 
capacity has been determined in histological analyses of these treatments, because in 
most cases, a dense fibrous connective tissue capsule could be observed around the 
graft materials[53].
3.3 Growth factors
Local delivery of bioactive agents or growth factors to the root surface, to initiate the 
healing process, is another approach to induce periodontal regeneration. For example, 
enamel matrix derivative (EMD), platelet-derived growth factor (PDGF) and insulin-
like growth factor-I (IGF-I) have shown to enhance periodontal tissue regeneration in 
animal experiments and clinical trials[54-56]. In addition, bone morphogenetic proteins 
(BMPs) have also demonstrated the potential to promote alveolar bone and cementum 
formation in periodontal defects[57,58].
Among these growth factors, EMD is the most widely tested and used one for 
periodontal regeneration in clinic. EMD is an extract of porcine immature enamel 
matrix, and used to biomimetically stimulate regeneration of the tooth surrounding 
soft and hard tissues following tissue destruction[59,60]. Periodontal regeneration 
facilitated by EMD is based on a developmental concept. According to the 
developmental process of root and periodontium, HERS, which is the apical extension 
of the enamel organ, induces the root dentin formation by mesenchymal cells of the 
dental papilla. Then, the HERS disintegrates and deposits enamel matrix proteins 
on the root surface to initiate cementogenesis and the development of periodontal 
attachment apparatus[5]. The enamel matrix consists of several proteins, 90% of 
which are amelogenins with slight amounts of enamelin and other proteins. Such 
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proteins are thought to induce migration, adhesion, proliferation, differentiation 
and mineralization of cells in periodontal tissue, and can induce the formation of 
the periodontal attachment during tooth formation[61]. Emdogain® (Straumann AG, 
Basel, Switzerland) is the only commercially available product using EMD. It received 
US Food and Drug Administration (FDA) approval and has been applied in clinic for 
over two decades. In principle, EMD, which seems to be safe, was able to achieve 
regeneration of lost periodontium in periodontal defects to some extent, according 
to clinical parameters. A Cochrane review of thirteen randomised controlled clinical 
trials revealed that significant pocket depth reduction (0.9 mm) and improved probing 
attachment levels (1.1 mm) could be achieved at one year after EMD application[60]. 
However, it is suggested that the results must be interpreted with great caution 
because of the high degree of heterogeneity observed among the trials. There was also 
no evidence of a clinical relevant difference between EMD and GTR. Ten-year results, 
following treatment of periodontal intra-bony defects with EMD and GTR, indicated 
both a positive clinical outcome with no statistically significant difference between 
EMD, GTR as well as the combination of EMD and GTR[62].
In addition, it must be noticed that the clinical significance of these procedures 
remains to be fully demonstrated, because very limited situations are applicable for 
these procedures, such as intra-bony defects where vertical bone loss around single 
teeth or furcation are involved. Accordingly, in most cases where a regular horizontal 
periodontal attachment loss is present, limited or no effect could be gained from these 
regenerative procedures currently.
4  Cell-based tissue engineering approaches for 
periodontal regeneration
The nature of periodontal defect healing after regenerative therapy can be classified 
as follows: long junctional epithelium (epithelial downgrowth interposing between the 
treated root surface and the gingival connective tissue); connective tissue attachment 
(collagen fibres inserted into the newly formed cementum, but not connected to the 
newly formed bone); connective tissue adhesion (direct contact of connective tissue 
to the root surface without apparent cementum formation); osseous repair (direct 
contact of newly formed bone to the root surface without apparent periodontal 
ligament formation); and finally regeneration (the ideal periodontal healing pattern 
where formation of new cementum occurs with inserted and functionally oriented 
fibres functionally and new bone is deposited)[63]. In view of the shortcomings of 
currently available clinical treatment strategies, regeneration of the periodontium 
is still not effective and highly unpredictable. Therefore, in order to alleviate the 
general introduction
23
1
limitations of conventional therapeutic procedures, the field of tissue engineering has 
emerged as a promising approach[64,65]. The tissue engineering approach to periodontal 
regeneration classically involves three components: scaffolds, cells, and biological 
cues. For cell-based tissue engineering strategies, primary derived stem cells are 
expanded or conditioned in vitro, then seeded into scaffolds with adding biological 
cues to generate advanced grafts for tissue regeneration. Finally, these constructs are 
implanted into surgical defects to regenerate the lost tissue.
Compared with the conventional regenerative therapy, a cell-based tissue engineering 
approach shows several advantages, such as the direct placement of cells and growth 
factors into defect, which greatly shorten the expected lag phase for progenitor cells 
recruiting to the defect site[66]. A successful application of tissue engineering strategies 
in periodontal regeneration requires the following vital factors: (1) a sufficient 
supply and survival of progenitor cells, which are capable of differentiating into the 
specific periodontal tissue-forming phenotypes, such as osteoblasts, osteoclasts, 
cementoblasts and fibroblasts; (2) adequate biological signalling to induce cellular 
differentiation, vascularization and tissue formation; (3) three-dimensional 
extracellular matrix scaffolds to support and promote this regenerative process; (4) 
appropriate mechanical stimulation to promote the formation of highly organized and 
functional periodontal tissues[67-69]. Additionally, since periodontium is chronically 
exposed to an oral microbiome[70], interventions about the infection and host immune 
response should also be considered to optimize periodontal regeneration.
4.1 Cells
Stem cells feature the capacity to extensive self-renewal and proliferation as well as 
a multilineage differentiation potential, which involves the differentiation of stem 
cell into specific tissue-forming phenotypes. From a wide variety of tissues, different 
stem cells populations have been isolated, identified and characterized. To date, three 
main sources have been identified: embryonic stem cells, adult stem cells and induced 
pluripotent stem (iPS) cells. Regarding periodontal regenerative therapy, a favourable 
source of stem cells should be easy to harvest, highly proliferative in vitro, flexible 
to extended processing, nonimmunogenic and possess the ability to differentiate 
into the specific periodontal cell types. Therefore, adult stem cells are emerging as 
the preferred cell type for regenerative therapies, because their isolation and use 
have already been accepted, while the use of embryonic stem cells is hampered by 
legal and ethical issues. iPS cells are created by genetic manipulation, which might 
result in an unpredictable behaviour and tumorigenic properties. Since the discovery 
of adult stem cells, it has been recognized that their developmental capabilities are 
great. Besides being responsible for maintaining tissue homeostasis in their original 
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site, it has also been confirmed that they can differentiate into other cellular lineages 
beyond their tissue(s) of origin. Adult stem cells have already been widely utilized in 
periodontal regeneration, including stem cells of dental tissue origin (PDL cells, dental 
pulp stem cells, dental follicle cells and root apical papilla stem cells), and non-dental 
tissue origin (bone marrow-derived mesenchymal stem cells and adipose-derived 
stem cells).
4.1.1 PDL cells
PDL cells consist of heterogeneous cell populations at different lineage commitment 
and differentiation stages. Among them, a subpopulation of stem cells which can 
maintain and regenerate periodontal tissue structure and function has been identified, 
which were first isolated from the PDL of extracted human third molar[16]. These cells 
exhibit multilineage differentiation potential, as demonstrated by their ability to 
differentiate into osteoblasts, cementoblasts and fibroblasts. The identification and 
isolation of mesenchymal stem cells (MSCs) from the PDL tissue has paved the way for 
the development of new approaches for periodontal regeneration. 
PDL cells can be isolated from the PDL tissue on either the root surface after tooth 
extraction or the alveolar bone surface of the extraction socket[71]. Recently, it is 
suggested that inflamed PDL tissue can also be utilized for PDL cells isolation, and 
that the regenerative potential for cementum, PDL and alveolar bone is still remained 
in these PDL cells[72]. As to the molecular markers, a specific marker of PDL cells has 
not been identified yet, but PDL cells present the typical properties of bone marrow-
derived mesenchymal stem cells (BMSCs), for instance their self-renewal capacity and 
part of their surface markers, such as STRO-1 (putative stem cell marker), CD13, CD44, 
STRO-3 (tissue-nonspecific ALP), CD90 (Thy-1), CD29 (integrin-1), CD105 (endoglin), 
CD146 (perivascular cell marker), CD106 (vascular cell adhesion molecule-1) and 
CD166 (activated leukocyte cell adhesion molecule), and also some embryonic 
markers, including stage-specific embryonic antigen (SSEA)-1, octamer-binding 
transcription factor (OCT)-4 and SSEA-4[73]. Despite differentiating into periodontium 
forming cells, in vitro differentiation of PDL cells also demonstrated their potential to 
differentiate into chondrocytes, adipocytes and neurocytes, which is similar to BMSCs 
and suggests that PDL cells might belong to a unique population of somatic stem 
cells[74,75]. Animal experiments (in dog, rat, pig and sheep) using PDL cell implantation 
within different biomaterial scaffolds have shown promising results in periodontal 
tissue regeneration[76-78]. Recently, a systematic review of 43 animal experiments 
testing the implantation of PDL cells in various types of periodontal defects indicated a 
beneficial outcome for periodontal regeneration, with 70.5% of the results presenting 
statistically significant improvement in new cementum, new connective tissue and 
new bone formation[79].
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In addition, recent studies revealed that PDL cells possess immunosuppressive 
properties and low immunogenicity, which might solve the problem of insufficient 
supply in autologous transplantation of PDL cells, due to the variation of disease 
state of each patient and stem cell potential between donors. This makes PDL cells 
promising candidates for allogeneic cell-based therapies[80,81]. An animal experiment 
using minipigs showed that allogeneic transplantation of PDL cells promoted 
alveolar bone regeneration in a defect model of periodontitis without any sign of 
immunological rejection[82]. Another study also reported an immunomodulatory role 
of PDL cells in negatively regulating DC-mediated T-cell immune responses, confirming 
their potential to be employed in new cell-based therapies[83].
More recently, clinical applications of PDL cells for periodontal regeneration have 
been investigated. In general, autologous PDL cell implantation is safe and does 
not produce significant adverse effects[84,85]. However, the currently only published, 
randomized clinical trial demonstrated no statistically significant differences between 
the cell implantation group (treated with GTR and PDL cell sheets in combination 
with Bio-oss®) and the control group (treated with GTR and Bio-oss® without cells)[86]. 
Multicentre, randomized controlled studies with a large sample size are required to 
validate further the efficacy of PDL cell-based periodontal therapy.
4.1.2 BMSCs
MSCs are defined as self-renewing and multipotent cells, which can differentiate into 
multiple cell types, including osteocytes, adipocytes, chondrocytes, hepatocytes, 
neurons, myocytes and cardiomyocytes. Friedenstein et al. first identified MSCs in 
aspirates of adult bone marrow and they demonstrated that these cells were capable to 
form fibroblastic colony-forming units or clonogenic clusters of adherent fibroblastic-
like cells with the potential to extensive in vitro expansion and differentiation into 
different stromal cell lineages[87-89]. Through the past decades, great efforts have 
been made to develop MSCs into a new therapeutic approach for treating various 
tissue defects and immune-mediated diseases in the clinic. Among them, BMSCs 
have became the most widely investigated MSCs due to their easy accessibility 
in quantities appropriate for clinical use, higher in vitro growth capacity than PDL 
cells, and multilineage differentiation potential[90,91]. Also, BMSCs possess similar 
immunosuppressive properties and low immunogenicity compared to PDL cells[92]. 
Animal experiments demonstrated that BMSCs were competent to regenerate both 
bone tissue and periodontal tissue in a variety of animal models[93-95]. For example, 
autologous transplantation of BMSCs into experimental class III furcation defects in 
beagle dogs induced periodontal regeneration, where the regeneration of cementum, 
PDL, and alveolar bone was observed[96]. In addition, in vivo transplantation of 
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green fluorescent protein (GFP) labelled BMSCs into an experimental periodontal 
defect demonstrated promising regeneration of lost periodontal tissues. 
Immunohistochemical analysis at four weeks after transplantation showed GFP-
positive osteoblasts, cementoblasts, fibroblasts and osteocytes in the newly 
formed periodontal tissue, which indicates that the transplanted BMSCs survived 
and differentiated into specific periodontal tissue-forming cells, promoting the 
regeneration of periodontal tissue[97].
Regarding the in vitro conditioning of BMSCs before in vivo implantation, conventional 
procedures mainly include maintenance of their multilineage differentiation 
potential as well as culturing in osteogenic differentiation medium. More recently, a 
chondrogenic differentiation approach of BMSCs has been introduced[98], where the 
isolated BMSCs are seeded into scaffolds, then expanded in vitro and cultured in 
chondrogenic differentiation medium to fabricate cartilage templates. After reaching 
the hypertrophic stage, the cartilage templates are implanted in vivo to regenerate the 
lost periodontal tissues. This approach follows the paradigm of tissue engineering, 
and makes full use of the properties of hypertrophic chondrocytes, which can thrive 
with limited nutrition and oxygen, secrete VEGF to promote blood vessel ingrowth, 
and recruit a mixture of cells. Animal experiments have been done and demonstrated 
regeneration of periodontal ligament and alveolar bone in 3-wall intra-bony periodontal 
defects in rats[98].
4.1.3 Dental pulp stem cells (DPSCs)
The dental pulp has been considered as an organ with great regenerative and reparative 
potential, because dental pulp cells can differentiate into osteoblasts to support bone 
formation and into odontoblast-like cells for reparative dentine formation. Therefore, 
dental pulp cells are recognized as a potential stem cell source for cell-based therapy 
in oral maxillofacial, orthopaedics and periodontal regeneration[99,100]. DPSCs can be 
isolated from the dental pulp of deciduous human teeth, healthy adult dental pulp, 
and even inflamed pulps[101-103].
DPSCs have an MSCs phenotype and a potential to differentiate into osteoblasts/
osteocytes, chondrocytes, myocytes, adipocytes, neuronal cells, cardiomyocytes, liver 
cells and β cells of the islet of pancreas[104]. Since DPSCs can form bone-like tissues 
as well as pulp and dentine-like tissue, they can be utilized for bone and periodontal 
tissue regeneration[105,106]. In addition, DPSCs present a higher osteogenic potential 
than periosteal cells and BMSCs[107]. Animal experiments have confirmed that DPSCs 
can promote periodontal regeneration in 3-walled periodontal defects created by 
ligature-induced periodontitis in mongrel dogs[108]. Recently, some researchers have 
tried to apply DPSCs in the clinic for periodontal regeneration[109]. One vital third molar 
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from a chronic periodontitis patient was extracted and used as an autologous source 
of DPSCs. Subsequently, DPSCs were implanted into an intra-bony defect prepared 
around the mandibular right second premolar. After one year, the re-entry procedure 
confirmed that the defect was completely filled with bone-like tissue[109].
4.2 Scaffolds
It is widely supposed that tissue engineering scaffolds can optimize the beneficial 
effects of cell-based treatment, while controlling cell delivery, improving persistence 
and reducing washing out of the implanted cells as well as minimising poor 
engraftment[63,110]. Furthermore, the use of a scaffold enables the introduction of 
extra biological cues such as growth factors to modulate the differentiation process 
or angiogenic factors to improve vascularization in the defect site[111]. Based on this 
concept, various tissue engineering scaffolds have been developed for periodontal 
regeneration. In principle, the ideal scaffold must possess the following essential 
factors: (1) a three-dimensional structure with proper mechanical support in view 
of the function of the target tissue; (2) optimized surface properties that facilitate 
cellular attachment, migration, proliferation and differentiation; (3) a highly porous 
interconnected network that enables diffusion of oxygen and cellular nutrients; 
(4) certain mechanical and biological cues to modulate cell behaviour, and (5) 
biodegradability at a controllable rate to complement cell/tissue growth and 
maturation. For periodontal regeneration, a plethora of different biomaterials in 
various forms have already been employed, such as biomaterials of natural origin 
(collagen, gelatin, chitosan, alginate), synthetic polymers (polylactic acid, polyglycolic 
acid, etc.), ceramics (calcium phosphate, hydroxyapatite, tricalcium phosphate) and 
metallic biomaterials (titanium and its alloys). These will be discussed in subsequent 
paragraphs. 
4.2.1 Biomaterials of natural origin
The ideal tissue engineering scaffold should mimic the natural structure and 
composition of tissues, and in this regard, biomaterials of natural origin are capable 
of guiding cells through the various developmental stages and to promote tissue 
regeneration[112]. The major advantage of utilizing natural biomaterials, such as 
collagen, alginate, chitosan and fibrin as a cell carrier material is their typically good 
biological characteristics, similarity to the ECM and inherent cellular interactions[113]. 
Previous studies have shown that natural biomaterials can be used to regenerate 
periodontal tissues as well as dental pulp[114,115]. However, certain limitations of these 
biomaterials, such as the potential pathogenic contamination when harvested from 
human sources or animal, must be carefully considered before application.
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Due to its safety related to its biological features and excellent biocompatibility, 
collagen is considered as one of the most suitable biomaterials. Therefore, it has been 
widely applied as a carrier material for cell transplantation. Collagen membranes 
and sponges possess essential features for cell adhesion, integration and tissue 
regeneration[116]. Animal experiments showed that the implantation of BMSC-loaded 
collagen-hydroxyapatite scaffolds into periodontal defects in beagle dogs induced 
periodontal tissue regeneration, with no aberrant events complicating the healing 
process[117]. Recent clinical trials also showed that periodontal regenerative therapies 
comprising EMD, deproteinized bovine bone mineral and collagen membrane resulted 
in positive clinical outcomes for 18 periodontitis patients with intra-bony defects and 
did result in a decreased tooth mobility[118]. 
Gelatin is a denatured product from collagen. It exhibits lower antigenicity compared 
to natural collagen. Gelatin sponge has been applied as a haemostatic material, 
which offers excellent biocompatibility, biodegradability, and low immunogenicity. 
The porous structure and hydrophilic surface of gelatin sponge allows for its use as 
carrier for the local delivery of cells and proteins as well[76,119,120]. Recent studies have 
utilized gelatin sponges in PDL cell implantation[76], the chondrogenic differentiation 
approach of BMSCs[98], and the preparation of chemo attractive constructs loaded 
with SDF-1α [115]. These studies demonstrated a favourable periodontal regeneration in 
terms of newly formed functional periodontal ligament and alveolar bone. Also, gelatin 
is used in combination with other biomaterials. For example, a gelatin-chondroitin-
hyaluronan tri-copolymer scaffold was fabricated to deliver dental bud cells in swine 
and the results of this study showed the regeneration of dentine-pulp complex with 
cementum and PDL[121].
4.2.2 Synthetic polymers
Synthetic polymers have several benefits compared with natural biomaterials. For 
example, they can be fabricated in almost unlimited quantities, and be prepared with 
controlled physical and chemical characteristics. Their physiochemical properties, 
such as mechanical strength and degradation rate, can be simply altered by chemical 
modification. In addition, desired scaffold architectures can be easily produced by 
electrospinning, 3D printing, fused deposition modelling, and so on. In the biomedical 
field, the most widely used synthetic polymers are poly(lactic acid) (PLA), poly(glycolic 
acid) (PGA) and their copolymers poly(lactic-co-glycolic acid (PLGA). These polymers 
are easier to handle in terms of their macro-/micro-structural preparation and 
possess a higher primary stability than natural biomaterials. Both the degree of 
hydrophobicity/hydrophilicity and the rate of hydrolysis-mediated degradation can be 
modulated by altering the ratio of PGA to PLA in PLGA to meet the requirements when 
used for tissue engineering. 
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Regarding periodontal regeneration, a highly porous three-dimensional electrospun 
PLGA/poly(ε-caprolactone) (PCL) scaffold was used to deliver chondrogenic 
differentiated BMSCs in a rat periodontal defect[98]. Also, a biodegradable PLGA 
sponge loaded with cementoblasts was used to regenerate the lost periodontium 
in a periodontal fenestration model in rodent. Results showed that by using this 
polymer sponge as cell carrier for delivering cementoblasts into periodontal wounds, 
an evident ability of cementoblasts to induce mineralisation could be observed[122]. 
Besides, in GTR procedure, PLGA membranes are commonly applied as barrier 
membrane. For example, a PLGA-based membrane was designed and fabricated with a 
surface morphology that can guide osteoblast migration at its ventral (defect) side and 
inhibit epithelial cell migration as well as proliferation at its dorsal (gingival) side[123].
4.2.3 Ceramics
Ceramics, such as bioactive glass and calcium phosphates (CaPs) are non-metallic, 
inorganic materials, but show a brittle behaviour. They possess outstanding 
properties, such as being capable of bonding directly to bone tissue, have a similar 
composition to bone mineral, and are osteoconductive, which makes them suitable for 
alveolar bone regeneration[124,125]. The most widely used CaP ceramics, like tricalcium 
phosphate (TCP), hydroxyapatite (HA) and bi-phasic calcium phosphate (HA/TCP), are 
available in various physical forms, such as blocks, particulates, cements, composites 
with polymers and coatings on titanium implants.
One of the most accepted materials is β-TCP, which possesses high biocompatibility 
as well as biodegradability and is claimed to be osteoinductive[126]. It has long been 
used as a drug delivery vehicle in periodontal therapy in both pre-clinical and clinical 
trials. Recent evidence suggests its important role as a cell vehicle that supports 
periodontal regeneration, especially in the combined use with other materials, such as 
chitosan, HA or collagen[127-129]. A combined compartmentalized system was tested in 
rats for periodontal regeneration: a platelet lysate (PL)-based membrane was placed 
along the denuded root surface aiming to regenerate the periodontal ligament and 
root cementum; a calcium phosphate cement incorporated with PL loaded hyaluronic 
acid microspheres was injected into the intra-bony defect, aiming to promote the 
alveolar bone regeneration. Results showed positive regenerative effect of the 
compartmentalized system, where significant connective tissue attachment and new 
bone formation were obtained[130,131].
4.3 Biomolecules
As already been discussed in section 3.3, the local delivery of bioactive agents or 
growth factors (such as EMD, PDGF, IGF-I and BMPs) to the root surface is another 
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approach to induce periodontal regeneration. More recently, the concept of 
endogenous cell recruitment has emerged as an appealing and suitable approach to 
modulate the early phase of wound healing, which has also been proposed to be the 
main goal of periodontal therapy[132,133]. 
SDF-1α is a chemokine that plays a vital role in the homing of CD34+ stem cells and 
cell recruitment[134]. It acts as a chemoattractant for periosteal progenitor cells, 
mesenchymal stem cells and hematopoietic stem cells. It also supports cell survival 
and proliferation. A dose-dependent migratory effect of cells stimulated with SDF-
1α was observed in vitro[135]. Furthermore, several in vitro studies have suggested 
the potential of SDF-1α for periodontal regenerative therapies[136,137]. Particularly, 
it has been demonstrated that SDF-1α can induce migration and proliferation of 
human PDL stem cells in vitro[138]. The optimal effect appeared at a concentration of 
200 ng/ml SDF-1α. It has been speculated that a short-term treatment with SDF-1α 
may induce an early increase in collagen and bone matrix formation. In addition, SDF-
1α in combination with BMP-7 can recruit multiple cell lineages to form a putative 
periodontal ligament and new bone, as demonstrated in vivo[139]. Also, as result of SDF-
1α signaling, BMSCs have been found to migrate favourably to the periodontal tissue 
compared to other organs and to become involved in periodontal healing. A pathway 
for cellular communication between the bone marrow and periodontal tissues has 
been described in this study[140].
Recent animal experiments showed that new bone formation and functional ligament 
length was significantly increased by applying an SDF-1α/gelatin sponge construct in 
periodontal defects created in rats[115]. At 6 weeks after implantation, no gelatin sponge 
was found in the defect upon visual inspection. Obviously, SDF-1α was released from 
gelatin sponge during this degradation process and managed to exert its effect. 
Other studies utilizing SDF-1α in periodontal therapy have also reported a significant 
regenerative effect. For example, a 6-fold increase in bone formation was observed in 
an SDF-1α mediated GBR procedure[141], and application of a SDF-1α loaded collagen 
membrane in a rat mandibular bone defect model demonstrated similar positive 
results on bone formation[142]. 
5 Objectives of this thesis
The goal of periodontal regenerative therapy is the full regeneration of damaged or 
lost periodontal tissues (root cementum, periodontal ligament, alveolar bone and 
gingival) to their original state and function. However, due to the unique structure 
and composition of the periodontium, and its lack of regenerative potential, this goal 
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is still challenging. The emergence of tissue engineering has paved the way for the 
development of new approaches for periodontal regeneration. Therefore, the overall 
objective of the current thesis was to develop cell-based tissue engineering strategies 
for periodontal regeneration. In particular, the studies focused on (1) utilizing dental 
postnatal cell-cell interaction in fibrous three-dimensional scaffolds for dental tissue 
engineering applications; (2) testing the differentiation approaches using BMSCs for 
periodontal regeneration; (3) optimizing the chondrogenic differentiation approach 
for periodontal regeneration and clinical translation through modulating scaffolds 
material; and (4) investigating the cell homing approach for periodontal regeneration.
More specifically, the following research questions are covered:
1  Is the co-culture of postnatal dental mesenchymal cells and dental epithelial cells 
in 3-dimensional (3-D) porous electrospun scaffolds a suitable approach for dental 
tissue engineering?
2  Which differentiation approach of bone marrow stromal cells (BMSCs) before 
implantation is favourable for periodontal regeneration?
3  Can enhanced periodontal regeneration through a chondrogenic differentiation 
approach be achieved by using a gelatin sponge, which has a relatively faster 
degradation rate and lower immunogenicity than a previously applied PLGA/PCL 
electrospun scaffold?
4  Can a cell homing approach using gelatin sponge as scaffold be an alternative 
strategy for periodontal regeneration instead of cell implantation approaches?
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1 Introduction
Due to the limited regenerative capacity of human deciduous and adult tooth tissues, 
tooth loss caused by caries, trauma, periodontal disease, and genetically inherited 
disease, is considered to be a major health issue. Current clinical treatment, including 
dental implant placement or fixed and removable dentures, can partially restore the 
lost function. However, the ability to replace lost teeth with a vital, bioengineered tooth 
would be highly preferred. The creation of fully functionalized bioengineered teeth, 
which contain dentin, enamel, dental pulp, blood vessels, nerves and periodontal 
ligament, is the ultimate goal in dental regenerative therapy.[1-3] 
Natural teeth develop from ectodermal dental epithelial (DE) cells and neural crest-
derived dental mesenchymal (DM) cells, whose interactions have been shown to 
be essential for dental cell differentiation and tooth development.[4,5] DE-DM cell 
interactions are also essential for bioengineered tooth regeneration. Previous studies 
illustrated that single tooth regeneration could be achieved by using a re-aggregation 
system, where a construct of DE cells harvested from embryonic tooth buds was 
combined with embryonic DM cells, and then transplanted and grown in the omentum 
or alveolar bone of host animals.[6] However, the use of cells harvested from early 
stage embryonic tooth buds will be difficult, if not impossible, to translate into clinical 
application. Thus, the use of post-natal dental epithelial-mesenchymal cells for tooth 
regeneration has been extensively investigated. To date, published reports using 
this approach have shown the formation of small tooth crowns present throughout 
the scaffold rather than one full-sized tooth, and that tooth root development was 
only rudimentary.[7-9] Even using three dimensional (3D) pre-fabricated DE-DM cell 
constructs, the formation of mineralized dental tissue was not satisfactory.[10]
These results emphasize the importance of appropriate scaffold materials and design, 
to establish proper DE-DM cell interactions for tooth regeneration. Electrospinning, 
as a simple and versatile method to produce nano- and micro-scale fibrous 
polymeric meshes, holds promise in this application.[11] Since electrospun fibres 
are morphologically similar to natural extracellular matrix (ECM), they can provide 
appropriate cues to direct dental cell proliferation and differentiation. Moreover, 
bioactive particles, such as nano-hydroxyapatite (nHA) which showed positive effect 
on osteogenic differentiation of bone marrow-derived mesenchymal cells, can easily 
be integrated into tooth scaffolds during electrospinning.[12,13]
A major concern, especially with electrospinning, is the creation of scaffolds with 
sufficient porosity.[14] Most current electrospinning techniques create scaffolds 
with insufficient inter-fibre space to simulate the physiological three dimensional 
tissue microenvironment and proper cell infiltration.[15,16] To solve this problem, wet 
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electrospinning techniques have been developed. During this process, electrospun 
fibres are collected in a liquid bath (e.g. ethanol) to form a random three dimensional 
structure.[17] Previous reports have also shown that the spatial density of electrospun 
fibres could be further improved by ultrasonic separation.[18]
To address all of these aforementioned issues, we have taken the following approach. 
First, 3D fibrous scaffolds were fabricated using wet electrospinning; Secondly, 
ultrasonic treatment and nHA were incorporated into the scaffolds preparation to 
improve the scaffold porosity and cell differentiation, respectively; and third, scaffolds 
seeded with DM cells alone, or a mixture of DE-DM cells, were investigated using in 
vitro cell culture. Replicate samples were examined for cell infiltration, proliferation, 
ameloblastic, odontoblastic and osteogenic differentiation, and DE-DM cell-cell 
interactions. We hypothesized that (1) wet electrospinning and additional ultrasonic 
treatment can improve scaffold porosity; (2) incorporation of nHA improves DM cell 
differentiation; (3) the highly porous scaffold with or without nHA will benefit DE-DM 
cell-cell interaction. 
2 Materials and methods
2.1 Materials
Poly(lactic-co-glycolic acid) (PLGA; Purasorb® PDLG8515) and poly(ε-caprolactone) 
(PCL; LACTEL® Absorbable Polymers, inherent viscosity range: 1.0 - 1.3 dl/g) were 
purchased from Purac Biomaterials BV (Gorinchem, The Netherlands) and DURECT 
Corporation (Pelham, AL), respectively. Nano-hydroxyapatite (nHA; Budenheim, Tri-
Cafos P/c53-80) was kindly provided by Dr. Marc Bohner (RMS foundation, Bettlach, 
Switzerland). Dextran sodium sulfate (DSS) was purchased from Sigma-Aldrich 
(St. Louis, MO). Organic solvents 2,2,2-trifluorethanol (TFE; purity ≥ 99.8%) and 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP; purity ≥ 99.0%) were obtained from Acros 
(Geel, Belgium) and Sigma-Aldrich, respectively.
2.2 Scaffold preparation
Five different groups of scaffolds were prepared: 1) conventional electrospun scaffolds 
(2D); 2) wet electrospun scaffolds (3D); 3) wet electrospun scaffolds with ultrasonic 
treatment (3Du); 4) wet electrospun scaffolds supplemented with nHA (3DH); and 5) 
wet electrospun scaffolds with ultrasonic treatment and nHA supplement (3DHu). The 
preparation procedures were as follows. 
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To prepare electrospinning solution, PLGA/PCL (w/w = 3:1) was dissolved in TFE 
at a concentration of 0.12 g/ml. For the electrospinning solution containing nHA, a 
defined amount of nHA and DSS (w/v = 0.5%) was suspended in HFIP/TFE/phosphate 
buffered saline (PBS) (v/v = 10:9:1) solution by ultrasonic and vigorous stirring (UP50H 
Ultrasonic Processor, Hielscher Ultrasound Technology, Teltow, Germany) for 30 
minutes. Then PLGA/PCL (w/w = 3:1) was dissolved in the solvent at a concentration of 
0.2 g/ml. The weight ratio of polymer:nHA was 4:1. After magnetic stirring overnight, 
the prepared solution was fed into a plastic syringe with a blunt-end nozzle (18G), and 
fixed in the syringe holder of electrospinning machine (Esprayer ES-2000S, Fuence 
Co., Ltd, Tokyo, Japan).  
For conventional electrospun scaffolds, a flat aluminium foil was used to collect the 
fibres, positioned 20 cm under the nozzle. The feeding rate of electrospinning solution 
was 20 µl/min, and a high voltage of 18.0 kV was applied to generate a stable polymer 
jet. The collection time was about 4 hours. For wet electrospun scaffolds, a grounded 
bath filled with 100% ethanol was used as collector. The other parameters were similar 
to those in the preparation of conventional scaffolds. To obtain the desired thickness, 
the process was stopped every 10 minutes for fibre mesh collection. 
Subsequently, all the scaffolds were washed with Milli-Q water and lyophilized for 72 
hours, then punched into disk-shaped forms (6 mm) using a biopsy punch (Kai medical, 
Gifu, Japan). 3Du and 3DHu scaffolds were further treated by UP50H Ultrasonic 
Processor (cycle 1, amplitude 100%) in a 50 ml centrifuge tube filled with 50% ethanol 
solution for 75 seconds and 120 seconds, respectively. Thereafter, the scaffolds were 
lyophilized again and stored at -80°C. 
2.3 Porosity measurement
Porosity of the scaffolds was evaluated by a gravimetric measurement.[17] The volume 
of the electrospun scaffold (n = 4) was calculated by measuring the dimensions of 
the scaffold. The weight of the scaffold was also measured to determine the apparent 
density of the scaffolds (ρap). Porosity was then calculated by using the following 
formula:
porosity=(1-
ρ
ap )×100%
where ρ
m
 is the density of the blended PLGA/PCL (1.216 g/cm3) or PLGA/PCL/nHA 
(1.604 g/cm3), which was calculated based on the weight ratio and respective 
densities of each ingredient (ρ
PLGA
= 1.24 g/cm3, ρ
PCL
= 1.145 g/cm3, ρ
nHA
= 3.156 g/cm3, 
from manufactures’ databases).
ρ
m
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2.4 Cell culture and scaffold seeding
Pig dental epithelial (pDE) cells and human tooth pulp derived dental mesenchymal 
(hDM) cells were isolated as described previously.[19] The pDE cells were recovered 
from cryopreservation, seeded in a T175 cm2 flask (Corning Inc., Corning, NY), and 
expanded using epithelial medium [LHC-8, (GIBCO, Invitrogen, Carlsbad, CA), 
supplemented with 10% FBS, 1% penicillin/streptomycin/amphotericin, and 0.5 µg/ml 
epinephrine]. The hDM cells were expanded in mesenchymal medium [Advanced 
DMEM/F12 (GIBCO, Invitrogen, Carlsbad, CA), supplemented with 10% FBS, 25 µg/ml 
ascorbic acid, 1% penicillin/streptomycin/amphotericin, 1% Glutamax] after recovery 
from cryopreservation. Cells were cultured at 37°C in a humidified 5% CO
2
 atmosphere. 
The media for both cell types was refreshed every 2 - 3 days.
To prepare cells for seeding scaffolds, the cells were trypsinized, centrifuged at 1500 
rpm for 5 minutes, then re-suspended in media. Scaffolds were sterilized in 70% 
ethanol for 2 h and socked in medium overnight at 37°C. Then a 15 µl cell suspension 
containing either hDM cells alone, or a mixture of pDE and hDM cells (1:1) was seeded 
to each scaffold, to achieve a final concentration of 2 × 105 cells/scaffold. Cell-seeded 
scaffolds were incubated at 37°C for 20 minutes in low-adhesive 24-well plates before 
adding medium. For further culture, osteogenic factors (100 nM dexamethasone, 10 
mM β-glycerolphosphate and 50 µg/ml ascorbic acid) were added to the medium. For 
samples containing both pDE and hDM cells, a mixture of epithelial cell medium and 
mesenchymal cell medium was used (v/v = 1:1). Scaffolds without cells were used 
as controls, receiving identical pDE/hDM culture medium with osteogenic factors. 
Samples were collected after 1, 4, 9, 14 and 28 days’ in vitro culture.
2.5 SEM analysis
Scaffold morphology of acellular control samples (days 1 and 28) was observed by 
scanning electron microscopy (SEM; Zeiss, EVO MA series, Göttingen, Germany) after 
being sputter-coated with gold-platinum. Fibre diameters were measured from SEM 
micrographs that were obtained at random locations (n = 25) using Image J software 
(National Institutes of Health, Bethesda, MD). 
Cell morphology on each type of scaffold (day 1 and 28) was also assessed by SEM. 
Samples were fixed in 2.5% (v/v) glutaraldehyde for 2 hours, washed with PBS, then 
additionally fixed with 1% (v/v) osmiumtetraoxyde for 2 hours. After been dehydrated 
in a graded ethanol, and dried in tetramethyl silane, samples were sputter-coated with 
gold-platinum, and imaged using SEM.
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2.6 Histological analysis
To visualize cell distribution throughout each sample, haematoxylin and eosin (H&E) 
and immunofluorescence (IF) staining was performed. Samples cultured in vitro for 1, 
14 and 28 days were washed in PBS, fixed in 3.7% (v/v) formalin for 5 hours, dehydrated 
in a graded ethanol, and embedded in paraffin. Following de-paraffinization in 
xylene and rehydration through graded ethanol, 7-µm-thick sections were cut with a 
microtome (Leica RM2165, Nuss-loch, Germany).
For H&E staining, sections were stained with Haematoxylin for 1 minute, then washed 
with tap water, diluted hydrochloric acid (0.3%) and ammonia water. Sections 
were next stained with eosin for 20 seconds, dehydrated with ethanol (95%, 100%) 
and xylene, and then mounted with coverslips using Permount (Fisher Chemicals, 
Pittsburg, PA). Micrographs were taken using a Zeiss Axiophot microscope equipped 
with digital Zeiss Axiocam camera (Zeiss, Stuttgart, Germany). 
For IF staining, pDE cells were stained with primary antibody rabbit-anti-human 
keratin (1:1 000, Euro-diagnostica, 2203PKE, Malmö, Sweden) and secondary 
antibody Alexa Fluor 594 Red antibody (1:50; Invitrogen, Life technologies Europe BV, 
A11012, Bleiswijk, The Nederland). Nuclei were counterstained with 4’,6-diamidino-2-
phenylindole (DAPI) according to standard protocol. Immunofluorescence images were 
obtained using a fluorescent microscope (Axio Imager Z1, Zeiss, Göttingen, Germany). 
Porcine skin control was used to confirm epithelial staining of the primary antibody. 
To control for non-specific staining, samples stained without primary antibody were 
included. 
2.7 DNA content and alkaline phosphatase (ALP) activity assays 
Samples (n = 4) from day 1, 4, 9, 14 and 28 were washed in PBS, then 1 mL of Milli-Q 
water was added to each well. After that, two freeze-thaw cycles were performed to 
lyse the cells. For the total DNA content assay, a Quan-iTTM Picogreen Kit (Invitrogen, 
Grand Island, NY) was used according to manufacturer’s instruction. Briefly, 100 µL 
supernatant was added to 100 µL Picogreen working solution. After 5 minutes 
incubation at RT, the amount of DNA was measured using an ELISA microplate reader 
(VersaMax, Sunnyvale, CA) with a 485 nm excitation filter and a 530 nm emission filter. 
DNA content was determined from a standard curve with known amounts of DNA.
For the ALP activity assay, 80 µL supernatant was added to 120 µL working solution 
(Alkaline phosphatase Liquicolor no. 2900, Stanbio, Boerne, TX), and incubated at 
37°C for 1 hour. Absorbance value at 405 nm was measured by an ELISA microplate 
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reader (VersaMax). The standard curve was made by serial dilutions of 4-nitrophenol 
at final concentrations of 0 – 25 nM. ALP activity was normalized to the DNA content.
2.8 Quantitative polymerase chain reaction (qPCR) 
After 14 and 28 days of culture, 3 scaffolds per group were pooled as one sample (n = 
2), and RNA of the seeded cells was extracted using RNeasy Mini Kit (Qiagen Sciences, 
74104, Valencia, CA) according to the manufacturer’s instructions. RNA concentration 
was measured with spectrophotometer (NanoDrop 1000, Thermal scientific, 
Wilmington, DE). Subsequently, first strand cDNA was reverse transcribed from RNA 
using Rt2 First strand kit (Qiagen Sciences, 330411), according to the manufacturer’s 
protocol.
cDNA was then amplified and specific gene expression was quantified using real-time 
PCR. Real-time PCR was performed using RT2 qPCR primers from Qiagen as specified 
in Table 1. Quantitative amplification detection was achieved using SABiosciences 
qPCR SYBR Green Master Mix (SABiosciences, Qiagen, 330521) in a real-time PCR 
(MxPro Mx3000P, Agilent technologies/genomics, Santa Clara, CA). Ameloblastic, 
odontoblastic and osteogenic-related gene markers were evaluated, including pig 
ameloblastin (pAMBN), human dentin sialophosphoprotein (hDSPP) and human 
bone gamma-carboxyglutamic acid-containing protein (hBGLAP), respectively. 
Housekeeping genes including pig glyceraldehyde 3-phosphate dehydrogenase 
(pGAPDH) and human Glyceraldehyde 3-phosphate dehydrogenase (hGAPDH) were 
used as reference genes. The cycling conditions were as follows: an initial 95°C for 10 
minutes, followed by 40 cycles of 95°C for 15 s and 60 °C for 1 minute. Then, a melting 
curve was constructed by heating at 95°C for 1 minute, 55 °C for 30 s and 95°C for 
30 s. All qPCR data differentiation markers were analysed using the 2-∆∆Ct method and 
normalized against a reference gene. Relative expression was measured by comparing 
different scaffolds at different time-point with the 2D scaffold. 
2.9 Statistical analysis
Data were expressed as mean standard ± deviation. Statistical analysis was carried out 
using Graphpad (GraphPad Inc, San Diego, CA) by one-way ANOVA and post hoc Tukey 
testing, for which differences were considered significant at p < 0.05.
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table 1 | Real-time PCR primers in this study.
Gene target RefSeq Accession no.a Reference positionb Qiagen catalog no.
hDSPP NM_014208.3 1318 330001 PPH57747E
hBGLAP NM_199173.4 357 330001 PPH01898A
pAMBN NM_214037.1 1610 330001 PPS00441A
hGAPDH NM_002046.4 828 330001 PPH00150F
pGAPDH NM_001206359.1 601 330001 PPS00192A
a  Sequence used for primer design.
b  Position of amplicon within gene.
3 Results
3.1 Scaffold characterization
By visual inspection, 2D scaffolds exhibited a compressed membrane-like structure, 
with thickness up to100 µm. In contrast, wet electrospun scaffolds exhibited a cotton-
like appearance. Ultrasonic treatment led to an even more loose scaffold structure, 
although scaffold diameter remained the same (~ 6 mm). Addition of nHA into wet 
electrospun scaffolds made the scaffolds denser. Even after ultrasonic treatment, 
3DHu scaffolds still appeared less porous than 3Du scaffolds (Figure 1). 
SEM micrographs of 2D and 3D scaffolds showed that ultrasonic treatment resulted 
in a more diverse fibre arrangement, and larger pores among fibres. For the scaffolds 
containing nHA, fibre diameters were visibly smaller than those without nHA, and some 
fibres were stuck together to form a dense structure. Also, aggregated HA particles 
could occasionally be observed (Figure 1). Fibre diameter measurement confirmed 
that the addition of nHA led to a decreased fibre diameter. None of the groups showed 
degradation of electrospun fibres or decreased fibre diameter after 4 weeks of in vitro 
culture (p > 0.05) (Table 2).
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figure 1 | Optical micrographs of 2D, 3D, 3Du, 3DH and 3DHu scaffolds; SEM images and H&E 
staining of each type of scaffold after 1 day and 28 days of culture without cells. Wet electrospun 
scaffolds exhibited a cotton-like appearance; ultrasonic treatment led to an even more loose 
scaffolds structure, and more gaps among fibres; Addition of nHA into wet electrospun scaffolds 
made the scaffolds denser, and led to a decreased fibre diameter. Arrows indicate the HA particles, 
some HA particles aggregated, and showed lager size than others; Scale bar = 2 mm in optical 
micrographs (1×); Scale bar = 10 µm in SEM images (2000×); Scale bar = 100 µm in H&E staining 
(40×).
The H&E staining of the cross-section views of the different scaffolds corroborated the 
SEM results (Figure 1). The 2D scaffolds showed evenly distributed fibres, whereas 
the 3D scaffolds were generally less organized, and showed more gaps among the 
fibres. Ultrasonic treatment induced a looser structure where larger gaps could be 
found. Incorporation of nHA was confirmed by the purple-stained particles found 
aggregated along the fibres. Finally, 3DHu showed elongated separations in the 
scaffold architecture. No differences in morphological appearance were noticed over 
the time of the experiment.
The porosity measurements (Table 2) showed the highest porosity in 3Du scaffolds 
(99.476 ± 0.151%), while the lowest porosity was found in 2D scaffolds (93.972 ± 
1.170%). Statistical analysis revealed that all wet electrospun scaffolds showed 
significantly higher porosities than the 2D scaffolds. Ultrasonically treated scaffolds 
showed significantly increased porosity compared to the non-treated ones. While nHA 
incorporation significantly decreased the scaffold porosity. 
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table 2 | Fibre diameter and porosity of the scaffolds. Note that the addition of nHA led to a 
decrease in fibre diameter. No changes in fibre diameter could be detected after 4 weeks of culture 
(p > 0.05, n = 25).
Scaffold Fibre diameter (day 1) Fibre diameter (day 28) Porosity (v/v) %
2D 2.239 µm ± 0.543 2.277 µm ± 0.665 93.972 ± 1.170
3D 1.918 µm ± 0.546 2.150 µm ± 0.247 99.068 ± 0.266
3Du 2.193 µm ± 0.783 2.198 µm ± 0.396 99.476 ± 0.151
3DH 0.767 µm ± 0.311 0.675 µm ± 0.397 97.801 ± 0.609
3DHu 0.983 µm ± 0.371 0.810 µm ± 0.435 99.000 ± 0.298
 
3.2 Cell morphology  
SEM micrographs (Figure 2) revealed even cell distribution over all scaffold types at 
day 1. Still, there was an evident difference between the scaffold with nHA and the 
scaffold without nHA. On 2D, 3D, and 3Du scaffolds, cells had penetrated in between 
the scaffold fibres. In contrast, on 3DH and 3DHu scaffolds, cells mainly attached to 
the outer surface, without visible infiltration into the scaffold porosity. After 28 days 
of culture, a thick layer of extracellular matrix had formed on the scaffolds surface. 3D 
and 3Du scaffolds, which had higher porosity than the other scaffolds, also showed 
cell ingrowth into the deeper parts of the scaffolds. No obvious visual differences 
could be detected on cell morphology between hDM culture groups and hDM+pDE 
culture groups (Figure 2).
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figure 2 | SEM images of 2D, 3D, 3Du, 3DH and 3DHu scaffolds seeded with either with hDM 
cells, or with hDM+pDE cells, at day 1 and at day 28. Even cell distribution over all scaffold could be 
found. Arrows indicate the evenly distributed cell at day 1, hollow arrows indicate the HA particles. 
Magnification = 2000×, scale bars = 20 µm; Lower magnification (500×) images were located in the 
upper-left corner of each image, scale bars = 40 µm.
 
3.3 H&E staining  
Cell distribution throughout the scaffolds was investigated by histological analysis 
(Figure 3). At day 1, all scaffolds seeded with either hDM or hDM+pDE cells exhibited 
a cell layer on top. 3D, 3Du, 3DH and 3DHu scaffolds also showed cellular ingrowth 
in between the fibres after cell seeding (data not shown). After 14 and 28 days of 
culture, cell proliferation and migration into the scaffold became evident for all groups. 
2D scaffold showed relatively poor cell infiltration at day 14, while the 3D scaffolds 
showed distribution of cells throughout the entire scaffold. Upon visual inspection, 
the hDM+pDE cell culture groups showed lower cell proliferation than hDM cell culture 
groups. Furthermore, evident clustering of cells in certain areas could be found in 3Du 
and 3DHu scaffolds seeded with hDM+pDE cells. Both scaffolds types containing nHA 
exhibited low cell proliferation, especially evident in hDM+pDE cell-seeded scaffolds.
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figure 3 | H&E staining of 2D, 3D, 3Du, 3DH and 3DHu scaffolds cultured with either hDM cells or 
hDM+pDE cells for 28 days. For each sample, low magnification (10×, scale bar = 500 µm) image 
provides the overview of cell distribution in the scaffold. High magnification (40×, scale bar = 
100 µm) image of the framed area displays cell morphology and possible cell-cell interaction. Cell 
proliferation and migration into the scaffold were obvious for all group. Evident clustering of cells 
could be found in 3Du and 3DHu scaffolds seeded with hDM+pDE cells.
 
figure 4 | Immunofluorescent staining with rabbit-anti-human keratin, Alexa Fluor 594 and DAPI. 
Cells stained in red are pDE cells, the other blue stained nuclei represent hDM cells. (A) 3D scaffold 
seeded with hDM+pDE cells at day 28, pDE cells tended to concentrate in the centre of the scaffold, 
surrounded by the hDM cells; (B) 3DHu scaffold seeded with hDM+pDE cells at day 28; (C) Positive 
staining of epithelial cells in porcine skin control; (D) 3D scaffold seeded with hDM cells at day 28; 
(E) 3D scaffold seeded with hDM+pDE cells at day 28 (stained without first antibody). 3D scaffolds 
seeded with either hDM or with hDM+pDE cells showed that cells could penetrate throughout the 
scaffold. Scale bars = 100 µm. 
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3.4 IF staining
To visualize the cell-cell interactions between hDM and pDE cells, and to identify pDE 
cells from hDM cells, immunofluorescent staining was performed (Figure 4). All nuclei 
were stained blue with DAPI. Rabbit-anti-human keratin and Alexa Fluor 594 was used 
to identify pDE cell staining (red). Figure 4C showed positive staining of epithelial 
cells in control tissue, i.e. porcine skin (keratin, red). No positive staining could be 
found in 3D scaffold seeded with hDM cells only (Figure 4D), or 3D scaffold seeded 
with hDM+pDE cells and stained without first antibody (Figure 4E). Therefore, the 
red stained cells were pDE cells, and the other blue stained nuclei in the hDM+pDE 
cell culture group represented hDM cells. In accordance with the H&E staining, 3D 
scaffolds seeded with either hDM or with hDM+pDE cells showed that cells could 
penetrate throughout the scaffold. pDE cells tended to concentrate in the centre of 
the scaffold, surrounded by the hDM cells (Figure 4A). In 3DHu group, pDE cells had a 
tendency to form denser cell clusters, where the rest of the scaffold was mainly filled 
by hDM cells (Figure 4B). 
 
figure 5 | DNA content (A) and ALP activity (B) on 2D, 3D, 3Du, 3DH and 3DHu scaffolds after 
cultured with either hDM cells or hDM+pDE cells for 4, 9, 14 and 28 days. All scaffolds seeded 
with hDM or hDM+pDE cells showed a significant increase in DNA content over time, although 
the mixed cell cultures showed weak initial proliferation in every scaffold type. For the scaffolds 
containing nHA, significant lower DNA contents were detected. The ALP activity of the 3DH group 
was significantly higher than the other hDM cell-seeded scaffold groups at day 4, and also the 
3DHu group showed significantly higher ALP activity than the other scaffold groups seeded with 
hDM+pDE cells at days 4, 9 and 14. Error bars represent standard deviation (n = 4).
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3.5 DNA content and ALP activity 
Cell number and ALP activity in each scaffold was quantified by total DNA content and 
ALP activity assays at day 4, 9, 14, and 28 (Figure 5A). In general, all scaffolds seeded 
with hDM or hDM+pDE cells showed a significant increase in DNA content over time, 
although the mixed cell cultures showed weak initial proliferation in every scaffold 
type. For the scaffolds containing nHA, significantly lower DNA contents were detected. 
In the hDM culture groups, the 2D group showed the highest DNA content at day 28, 
with no statistical difference with 3D group at day 4, 9 and 14. The 3Du group showed 
equally high DNA content with 2D and 3D groups at day 4 and 9, but exhibited lower 
DNA content at day 14. Although 3DH and 3DHu groups showed the lowest DNA content 
at day 4, hDM cells continued to proliferate on these scaffolds over time. In hDM+pDE 
cell culture groups, similar results were obtained. In particular, the 3DHu group showed 
significantly lower DNA content than the 3DH group, at days 9, 14 and 28.
For the ALP activity of hDM cell only seeded scaffolds (Figure 5B), the 2D, 3D and 3Du 
groups showed slightly increased ALP activity over time, with significantly higher 
ALP activity in the 2D group at day 9. The 3DH group showed significantly higher ALP 
activity than 2D, 3D, 3Du and 3DHu groups at day 4, with no statistical differences 
among these last 4 groups. ALP activity was lower at day 9, and increased gradually 
at day 14 and 28. A similar trend could also be found in the 3DHu group. Both the 3DH 
and 3DHu groups showed significantly higher ALP activity than the 2D group at day 
28. In the hDM+pDE cell-seeded scaffold groups, 2D and 3D groups showed a slightly 
increased ALP activity at day 9, which subsequently decreased over time. For the 3Du 
group, this trend was even more obvious, especially at day 9. Both the 3DH and 3DHu 
groups showed high ALP activity at day 4 and 9. In particular, 3DHu groups showed 
significantly higher ALP activity than the other groups from days 4 to 14. At day 28, ALP 
activity in hDM cell culture groups was significantly higher than that in hDM+pDE cell 
culture groups.
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figure 6 | Human DSPP (A, B, to evaluate the odontoblastic differentiation of DM cells) and 
human BGLAP (C, D, to evaluate the osteogenic differentiation of DM cells) gene expression in 
hDM cells after 14 days and 28 days of culture on different scaffolds. Pig AMBN (E, to evaluate the 
ameloblastic differentiation of DE cells) gene expression in pDE cells after 14 days and 28 days 
of cultured with different scaffolds. The gene expression level of either hDM cells or hDM+pDE 
cells seeded on 2D scaffold at day 14 was used for normalization. The red dash line indicates 
the gene expression level of the reference group. 3DHu group exhibited at least a 4-fold higher 
level of hDSPP and pAMBN expression than 3DH group at day 14 and 28; hDM+pDE cell culture 
groups showed comparative higher expression of hDSPP in most of the groups, but lower hDSPP 
expression in hDM cell alone groups; hBGLAP expression in hDM cell-seeded scaffold groups was 
much higher than that in hDM+pDE cell-seeded scaffold groups.
 
3.6 qPCR 
The mRNA expression of odontoblastic (hDSPP), osteogenic (hBGLAP) and 
ameloblastic (pAMBN) related genes markers was quantitatively analysed by qPCR. 
In hDM cell-seeded scaffold groups, an 18-fold higher level of hDSPP expression 
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was observed in the 3DH group, and an 8-fold higher level of hDSPP expression 
was observed in the 3DHu group at day 28, as compared to 2D, 3D and 3Du groups 
(Figure 6A). In hDM+pDE cell culture groups, scaffolds containing nHA also exhibited 
higher levels of hDSPP expression at days 14 and 28. Meanwhile, the 3DHu group 
showed at least 4-fold higher level of hDSPP expression than the 3DH group (Figure 
6B). Compared to the hDM cell alone seeded scaffolds, the 2D scaffold seeded with 
hDM+pDE cells presented higher levels of hDSPP expression at both days 14 and 28. 
As shown in Figure 6C and 6D, hBGLAP expression in hDM cell-seeded scaffold groups 
was much higher than that in hDM+pDE cell-seeded scaffold groups, which was in 
accordance with the ALP activity results obtained at day 28. In the hDM cell-seeded 
scaffold groups at day 28, no less than a 13-fold higher level of hBGLAP expression was 
observed in the 2D group as compared to the other groups.
Similar to the hDSPP gene expression results, scaffolds containing nHA exhibited 
higher levels of pAMBN expression as compared to the other hDM+pDE cell-seeded 
scaffold groups. Also, 3DHu group showed 4-fold and 6-fold higher level of pAMBN 
expression than 3DH group at day 14 and 28, respectively. No pAMBN expression could 
be detected in the hDM cell-seeded scaffold groups.  
4 Discussion
Although human incisor, canine, premolar and molar teeth exhibit distinct size, 
shape and morphology, their development basically begins in the same manner: the 
reciprocal interactions between the dental epithelium and the neural crest cell-derived 
ectomesenchyme.[2,20] By establishing proper methods to achieve accurate DE-DM 
cell-cell interactions, the in vitro formation of bioengineered tooth formation might be 
facilitated.[10,21] To date, the most successful tooth organ regeneration was obtained by 
seeding DE and DM cells harvested from E14.5 tooth buds into adjacent regions within 
a collagen gel drop.[6] However, such methods do not allow for translation to clinically 
achievable procedures, due to lack of autologous embryonic tooth cells to use for 
these applications, and that collagen gels do not provide appropriate stiffness to form 
teeth of pre-determined size and shape. No such results have yet been reported using 
post-natal dental cells, likely due to inappropriate cell-cell or cell-ECM interactions 
in a variety of scaffold materials used in these efforts. In the current study, wet 
electrospun PLGA/PCL scaffolds combined with or without ultrasonic treatment and 
nHA supplementation were fabricated and seeded with post-natal DE and DM tooth 
bud cells, in an attempt to establish 3D bioengineered tooth bud constructs in which 
more appropriate DE-DM cell interactions exist, to facilitate tooth regeneration. 
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Although electrospun scaffolds have the potential to resemble natural ECM, a common 
problem encountered with these scaffolds is an inherently low porosity, which inhibits 
adequate cellular infiltration.[15,16,22] Therefore, in the present study, wet electrospinning 
technique and ultrasonic treatment were employed to achieve highly porous PLGA/
PCL scaffolds. Furthermore, nHA was incorporated into the scaffolds to enhance 
dental cell differentiation. Overall, our results showed that wet electrospun PLGA/PCL 
scaffolds were highly porous and permitted ingrowth of hDM and pDE cells. Further 
ultrasonic treatment induced diverse fibre arrangement and large pores among the 
fibres, which led to evident cell clustering and thus to a more enhanced DE-DM cell 
interaction. Finally, the addition of nHA indeed had a positive effect on dental cell 
differentiation. However, such addition at the same time inhibited scaffold porosity 
and cell proliferation. 
Regarding the experimental design, several remarks can be made. Firstly, the cell 
seeding was performed in a static way. Earlier studies, using other cells and scaffold 
types, often applied dynamic seeding methods. For instance, the scaffolds were rotated 
in cell suspensions, or slight vacuum was used to enhance cell infiltration throughout 
the scaffold.[18,22] In a pilot study used to test this approach, a dynamic seeding method 
was found to create a rotational turbulence that over time proved to be too harsh for 
the DE cells (data not shown). Therefore, a static seeding method was used in the 
current study. Also, earlier investigations demonstrated that the cell seeding efficiency 
did not differ significantly between cell seeding methods.[23,24] Secondly, only hDM and 
hDM+pDE cell populations were tested in this study. This is due to the fact that prior 
published reports from our group showed that scaffolds containing nHA inhibited DE 
cell proliferation, and that DE cells seeded on their own would not survive during cell 
culture.[15,25]
In the present study, five different scaffolds were fabricated. The 2D scaffolds were 
prepared according to conventional electrospinning protocol.[26] Higher porosity was 
obtained by applying an ethanol collection bath (wet electrospinning) and further 
ultrasonic treatment. Moreover, the wet electrospun samples were prepared with or 
without the addition of nHA. Although we used “porosity” in scaffold characterization, 
of course the samples were not porous but rather were fibrous in nature. The porosity 
in this sense was regarded as an average inter-fibre space. As to the high porosity in 
the wet electrospun scaffolds, the effect of ethanol bath collection on the porosity 
was evident in SEM, porosity measurement and H&E staining results. Previous study 
demonstrated that ultrasonic treatment could loosen the densely packed electrospun 
poly(l-lactic) scaffolds.[18] By mechanically separating them through vibration for 5 
minutes, a 6-fold higher of fibre distance could be obtained. Also, it was assumed that 
such an effect would increase the porosity of wet electrospun scaffolds, and a larger 
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porosity would lead to better nutritional support, oxygen exchange and optimal cell 
infiltration. However, the results showed that the ultrasonic treatment mostly changed 
the homogeneity of the scaffold, with only a slight increase in porosity. This treatment 
did not lead to a uniform increase of inter-fibre distance, but rather to the creation of 
large gaps among fibres. Although unforeseen, this alteration in scaffolds architecture 
proved very beneficial in the cell culture. This special architecture namely lead to 
an apparent clustering of cells in hDM+pDE cell culture group, which subsequently 
optimally facilitated the interactions between hDM and pDE cells. 
As to the cell-cell interaction between hDM and pDE cells, both H&E and IF staining 
confirmed that ultrasonic treatment could induced intense clustering of hDM and pDE 
cells, while the distribution of these cells was relatively more separate in 3D and 3DH 
scaffolds. The 3Du and 3DHu scaffolds also supported the proliferation of hDM and 
pDE cells. The 3Du group showed equally high DNA content with 2D and 3D scaffolds 
at day 28, while cell proliferation in 3DHu group was inhibited by nHA. Both 3Du and 
3DHu group showed significantly higher ALP activity than 2D and 3D groups at day 9. 
Similarly, the qPCR results exhibited that 3DHu group exhibited at least a 4-fold higher 
level of hDSPP and pAMBN expression than 3DH group at day 14 and 28. Together, 
these results confirmed that ultrasonic treatment could induce cell clustering in the 3D 
scaffold, which could result in more intense hDM-pDE cell-cell interactions resulting 
in higher ameloblastic and odontoblastic differentiation. Interestingly, the fact that 
hDM+pDE cell culture groups showed comparative higher expression of hDSPP in 
most of the groups, but lower hDSPP expression in hDM cell alone groups suggest 
DE cells promote the differentiation of DM cells to odontoblastic direction rather than 
osteogenic direction. 
Regarding the incorporation of nHA into the scaffolds, the effect was seemed to have 
little effect. According to literature, nHA can enhance the attachment, proliferation and 
differentiation of bone forming cells, as well as in vivo bone generation.[27,28] Such nHA 
incorporation was shown to enhance the expression of osteogenic related genes in 
human mesenchymal stem cells, such as ALP, osteocalcin and bone sialoprotein, and 
promote ECM mineralization. In dental regeneration, a previous study also indicated 
that nHA had an effect on cell proliferation, differentiation and ECM production of 
porcine tooth bud cells.[15] Such results were partially similar to our current findings. 
In 3DH and 3DHu groups, DNA content did not increase much over time, and they were 
significantly lower than 2D, 3D and 3Du groups. The ALP activity of the 3DH group was 
significantly higher than the other hDM cell-seeded scaffold groups at day 4, and also 
the 3DHu group showed significantly higher ALP activity than the other scaffold groups 
seeded with hDM+pDE cells at days 4, 9 and 14. This could be interpreted as the result 
of DE-DM cells differentiating immediately after seeding under the influence of nHA, 
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and thus the actual cell proliferation was inhibited. Likewise, our qPCR results also 
indicated that incorporation of nHA benefited odontoblastic differentiation of hDM 
cells, and ameloblastic differentiation of pDE cells when co-cultured with hDM. Low 
expression of pAMBN in 3Du group suggest the cell clustering may not benefit the 
ameloblastic differentiation necessarily. The present of nHA is essential in this case. 
Still, in the current study, we also found that the nano-scale apatite crystals were of 
great influence to the spinning process. Scaffolds exhibited lower fibre diameter and 
porosity than the scaffolds without nHA, and exhibited a lesser uniform appearance, 
especially at the surface. Such undesirable side-effects of nHA on scaffold morphology 
have also been noticed by other researchers.[29] For future studies, higher fibre 
diameter and porosity of these scaffolds may be created using higher polymer 
concentrations and lower nHA content, or with a higher spinning flow rate. Other 
methods to incorporate or release nHA from the scaffold should also be investigated, 
and additional DE-DM cell stimulation by other means such as the addition of growth 
factors. 
5 Conclusion 
Based on our findings, and within the limitations of this study, it can be concluded that 
ultrasonic treated wet electrospun PLGA/PCL scaffolds are a suitable scaffold material 
for dental tissue engineering. In this study, wet electrospun scaffolds exhibited 
sufficient porosity to support dental cell ingrowth. Additional ultrasonic treatment 
led to a less homogeneous scaffold porosity, resulting in evident cell clustering, thus 
benefiting DM-DE cell-cell interactions. Finally, the addition of nHA had a positive effect 
on dental cell differentiation. However, the addition of nHA at the same time induced 
lower fibre diameter and porosity, as well as inhibited cell ingrowth and proliferation. 
Further in vivo evaluation of this cell-scaffold construct is warranted for the future.
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1 Introduction
Destructed periodontal tissues have limited potential to regenerate. The use of guided 
tissue regeneration (GTR) leads to minor, and highly variable clinical improvements[1]. 
Therefore, several recent studies have focused on the use of cell-based tissue 
engineering to achieve periodontal regeneration[2-5]. The principle of tissue 
engineering, is to expand or condition primary derived cells seeded on a biomaterial 
scaffold. Such a scaffold can subsequently be implanted into a periodontal defect to 
regenerate the lost tissue. 
Although cell transplantation has mainly been pursued with periodontal ligament 
fibroblast (PDL cells), also bone marrow-derived mesenchymal stem cells (MSCs) were 
studied. Bone marrow-derived MSCs show multilineage differentiation potential, are 
easily accessible, and exhibit a higher growth capacity than PDL cells[6,7]. Bone marrow-
derived MSCs are capable of regenerating not only bone tissue, but also periodontal 
tissue in various animal models[8,9]. Still, so far, no consensus regarding the optimal 
pre-culture conditions exists. In literature, several main approaches are distinguished, 
i.e. the retention of multilineage differentiation potential[4,10], the osteogenic 
differentiation approach[11], or a chondrogenic differentiation strategy[12,13].
The first approach is based on the notion that stem cells can participate directly to 
regeneration by differentiating into the progenitor cells of different tissues under the 
influence of the local microenvironment; or alternatively can regulate regeneration 
via secretion of trophic factors[14]. In the presence of fibroblast growth factor-2 
(FGF-2), MSCs can maintain their multilineage differentiation potential[15,16]. After 
transplantation, the local factors present in the host tissue can influence transplanted 
MSCs to differentiate into various connective tissue cells[17]. Recent data suggests 
that bone marrow progenitor cells can communicate with dental tissues and become 
tissue-specific mesenchymal progenitor cells to maintain tissue homeostasis[18]. 
Ultimately, this strategy could result in periodontal regeneration[2,4,10].
Secondly, the osteogenic differentiation approach hypothesises that establishment 
of a bony support is the first step in periodontal regeneration, after which functional 
loading from mastication may stimulate the formation of new ligament, as well as 
its organisation into a certain preferential direction[5]. Based on this hypothesis, pre-
culture of cell-seeded scaffolds in osteogenic medium, can be another conditioning 
approach[19,20]. It has already been shown that the use of a MSCs cell sheet, which was 
pre-cultured in osteogenic medium for 5 days and placed in a canine 1-wall periodontal 
defect, induced regeneration of hard as well as soft periodontal tissues[11].
Finally, several studies have been using a chondrogenic differentiation approach 
for bone regeneration[12,13,21]. In our group, a subcutaneous implantation experiment 
showed that such constructs have osteoinductive ability[22]. In this approach, bone 
is generated through the endochondral pathway instead of direct osteoblastic 
differentiation. The underlying principle behind this approach is that chondrocytes are 
able to survive with limited nutrition and oxygen. It has not been investigated whether 
this approach is also useful for periodontal regeneration.
Therefore, this study aimed to compare the efficacy of three different MSCs 
differentiation approaches for periodontal regeneration. In practice, a 3-dimensional 
fibrous wet-electrospun scaffold was used as the cell delivery vehicle. MSCs were 
seeded onto the scaffold and pre-cultured in different conditions to achieve desired 
differentiation status before implantation into a previously described intra-bony three-
wall periodontal defect model in Fischer rats[23]. Subsequently, histomorphometrical 
analysis was used to assess the regenerated periodontal tissues.
2 Materials and Methods
2.1 Fabrication and characterization of wet-electrospun scaffolds
Scaffolds were prepared using a wet-electrospinning technique as described 
previously[22]. Poly(lactic-co-glycolic acid) (PLGA; Purasorb® PDLG 5010), 
poly(ε-caprolactone) (PCL; inherent viscosity 1.0-1.3 dl/g) and organic solvent 
2,2,2-trifluoroethanol (TFE; purity ≥ 99.8%) were purchased from Purac Biomaterials 
BV (Gorinchem, The Netherlands), DURECT Corporation (Pelham, AL) and Acros (Geel, 
Belgium), respectively. 
Scaffold morphology was observed by scanning electron microscopy (SEM; JEOL6340F, 
Tokyo, Japan). The fibre diameter was measured from SEM micrographs that were 
obtained at random location (n = 90) using Image J software (National Institutes of 
Health, Bethesda, MD).
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table 1  | Cell culture media used in the experiment 
Abbreviation Full name Constituents Origin of constituents
BM Basic cell culture 
medium
α-MEM
10% fetal bovine serum (FBS)
100 U/ml penicillin
100 µg/ml streptomycin
Gibco
Sigma
Gibco
Gibco
FM
PM
FGF-2 medium
Proliferation medium
BM
3 ng/ml FGF-2
BM
50 µg/ml L-ascorbic acid
10 nM dexamethasone
R&D systems
Sigma
Sigma
OM Osteogenic medium PM
10 mM sodium β-glycerophos-
phate
Sigma
CM Chondrogenic medium high-glucose Dulbecco’s 
modified Eagle’s medium 
 1% FBS
100 U/ml penicillin
100 µg/ml streptomycin
50 µg/ml L-ascorbic acid
100 mM sodium pyruvate 
1:100 insulin-transferrin-se-
lenium 
100 nM dexamethasone
10 ng/ml transforming growth 
factor beta-2 (TGF-β2) 
100 ng/ml bone morphogenet-
ic protein 2 (BMP-2)
Gibco
Sigma
Gibco
Gibco
Sigma
Gibco
BD biosciences
Sigma
R&D systems
BD biosciences
 
2.2 Cell isolation, seeding and pre-culture
Bone marrow-derived MSCs were isolated from 7-week-old male Fischer rats after 
approval from Radboud University Nijmegen Animal Ethics Committee (Approval 
number: RU-DEC 2013-100). Briefly, both femora of each rat were extracted, epiphyses 
were cut off and diaphyses were flushed out using the basic cell culture medium (BM, 
Table 1). The flush-out of bone marrow from 5 rats was pooled and cultured for 2 days 
in a humidified incubator (37 °C, 5% CO
2
), after which the medium was refreshed to 
remove non-adherent cells. Cells from passage 2 were used for cell seeding. 
Disk-shaped scaffolds (Ø 2 mm; thickness 0.6 mm) were punched out (biopsy punch; 
Kai medical, Gifu, Japan) from electrospun meshes and treated with an ultrasonic 
processor (UP50H, Hielscher Ultrasonics, Germany) in 100% ethanol for 5 min to obtain 
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a very loose structure. Scaffolds were subsequently sterilized in 70% ethanol for 2 h 
and soaked in BM overnight at 37 °C. MSCs were seeded by soaking the scaffolds in a 
cell suspension containing 2.0 × 106 cell/ml (10 scaffolds per 1 ml cell suspension) and 
gently rotating for 2 h (Stuart® SB3, Jencons Scientific Ltd., Bedfordshire, UK). Then 
the non-attached cells from the suspension were collected, centrifuged and reseeded 
equally onto each scaffold to ensure highest cell loading efficiency. Culture medium 
was added to each well after 1 h. As a negative control, empty scaffolds without 
cells were prepared simultaneously. Finally, the constructs were pre-cultured under 
different condition:
1  For the retention of multilineage differentiation potential (FGF2) group, the 
constructs were cultured in FGF-2 medium (FM, Table 1) for 10 days;
2  For the osteogenic differentiation (O+) group, the constructs were cultured in 
osteogenic medium (OM, Table 1) for 10 days;
3  For the chondrogenic differentiation (C+) group, the constructs were cultured for 1 
week in proliferation medium (PM, Table 1) and then transferred to chondrogenic 
medium (CM, Table 1) for 4 weeks according to our previous study[22];
4  For the empty (EMP) group, empty scaffolds were kept in BM for 10 days.
2.3 In vitro assays
For in vitro assays, haematoxylin and eosin (HE), Safranin O and Von Kossa staining 
were performed to evaluate cell distribution, cartilage formation and in vitro 
calcification ability, respectively.
After pre-culture, samples were fixed in 10% phosphate-buffered formalin, dehydrated 
in graded ethanol and embedded in paraffin. Following deparaffinization in xylene and 
rehydration through graded ethanol, 6-µm-thick sections were cut with a microtome 
(Leica RM2165, Nussloch, Germany), and stained with HE or Safranin O (n = 5).
For Von Kossa staining, samples were further cultured for 21 days (FGF2 and C+ group) 
or 14 days (O+ group) in OM. Thereafter, samples were fixed in 10% phosphate-buffered 
formalin, decalcified in 10% EDTA, dehydrated in graded ethanol and embedded in 
paraffin. Microtome sections of 6-µm thick were stained with Von Kossa reagent to 
visualize the mineralized matrix, and counterstained with Nuclear Fast Red (n = 5). 
2.4 In vivo implantation
After pre-culture, the cell-scaffold constructs were implanted into bilateral intra-
bony three-wall periodontal defects in sixteen 7-week-old male Fischer rats (F344/
DuCrl, Charles River, Sulzfeld, Germany). The protocol was approved by Radboud 
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University Nijmegen Animal Ethics Committee (Approval number: RU-DEC 2013-100), 
all procedures were performed in accordance with the national guidelines for the care 
and use of laboratory animals.
Surgery was performed under general inhalation anaesthesia with a mixture of nitrous 
oxide, isoflurane and oxygen. An appropriate level of anaesthesia was achieved and 
maintained under pulsoxy and cardiac monitoring. The bilateral intra-bony three-wall 
periodontal defects were prepared mesially at both maxillary first molar as described 
previously[5,23] (Figure 1A-F). Following a 3 mm full thickness incision along the alveolar 
ridge mesially to the maxillary first molar, the mucoperiosteal flap was raised, and a 
defect was created along the root surface using a piezoelectric device (Piezosurgery®, 
Mectron, Carasco, Italy; equipped with OT5 B-tip; Ø1.7 mm). 
Subsequently, the residual alveolar bone, PDL and cementum were removed from the 
root surface using a less abrasive OP5-tip. This tip was also used to finalize the defect 
(W × L × D; 2 × 2 × 1.7 mm3), with constant size monitoring by a clinical periodontal 
probe. Thereafter, defects were rinsed with sterile saline, dried with a sterile gauze 
and filled with the constructs (2 constructs per defect, n = 8). Groups were randomized 
according to a “Latin Square” allocation. Ultimately, flaps were repositioned, and 
sutured with resorbable sutures (Vicryl® 5-0, Ethicon Products, Amersfoort, the 
Netherlands).
2.5 Histological preparation
Six weeks after implantation, rats were deeply anesthetized prior to 10% formalin 
cardiovascular perfusion. Complete maxillae were dissected and excess tissues were 
removed. After fixing in buffered 10% formaldehyde for 24 hours, the specimens were 
decalcified in 10% EDTA at room temperature, with X-ray examination to confirm the 
decalcification process. Subsequently, the specimens were dehydrated in graded 
ethanol. Before paraffin embedding, the molars were stained with black ink to 
ensure that sections were made in the area of interest. Sections of 6 µm thick were 
cut in mesio-distal direction with a microtome. Every 15th slide was stained with HE 
for general tissue assessment. For ligament, epithelial and bone tissue observation, 
adjacent sections were stained with Azan staining and Elastica-van Gieson (EVG) 
staining.
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figure 1 | Overview of the surgical procedure and new tissue measurement in the rat periodontal 
defect model: (A) preoperative general observation; (B) a 3 mm full thickness incision was made 
to expose the root surface and alveolar bone; (C) the created defect; (D) a periodontal probe was 
used to confirm the defect size; (E) implant placement in the defect; (F) flaps were closed with 
5-0 resorbable sutures; (G) Schematic drawing illustrating the histomorphometrical analyses of 
periodontal tissue regeneration: reference line 1 is drawn based on the cemento-enamel junction 
(CEJ) at the distal portion of first molar; reference line 2 is drawn based on the alveolar level of 
the intact bone; Relative alveolar bone height = L
ac
/L
bg
, where L
ac
 is the length of the mesial molar 
from apex to cusp, and L
bg
 is the length of bone gap, i.e. the distance from the regenerated bone 
level to the normal alveolar bone height level; Relative new bone area = A
nb
/A
df
, where A
nb
 is the 
area of new bone (within yellow frames), and A
df
 is the area of defect (within blue frame); Relative 
epithelial downgrowth = L
je
/L
ac
, where Lje is the length of junctional epithelial from the CEJ to the 
apical extent; Relative functional ligament = L
fl
/L
ca
, where L
fl
 is the length of functional ligament, 
and Lca is the distance from the CEJ to the apical end of the defect.
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2.6 Histomorphometrical analysis
For the quantitative analysis, three sections from the middle third of the defect area 
for each specimen were evaluated. Sections were photographed using a Zeiss Imager 
Z1 equipped with an AxioCam MRc5 camera operated with AxioVision 4.6.3 software 
(Carl Zeiss Microimaging GmbH, Göttingen, Germany). Measurements were performed 
using Image J software, as previously described[5] (Figure 1G). 
2.7 Statistical analysis
Data were expressed as mean ± standard deviation. Statistical analysis was carried out 
using Graphpad (GraphPad Inc, San Diego, CA) by one-way ANOVA and posthoc Tukey 
testing, for which differences were considered significant at p < 0.05.
3 Results
3.1 Scaffold characterization
The wet-electrospun mesh showed a loose, fluffy structure, with a diameter of 3 - 4 
cm and a thickness of 2 - 3 mm (Figure 2A). SEM images (Figure 2B) showed a porous 
fibrous structure with randomly dispersed fibres. The pores between fibres were about 
3 - 30 µm and the average fibre diameter was 2.25 ± 0.31 µm. 
figure 2 | The electrospun scaffold: (A) optical image shows a cotton-like and uncompressed 
structure; (B) SEM micrograph shows a porous and loose accumulation of fibres (1000×). 
chapter 3
78
3.2 In vitro assays
HE stained sections revealed that samples from the FGF2 and O+ groups were fragile 
and upon handling did not retain the original shape. The seeded cells were mostly 
found in the middle and edge of the scaffold (Figure 3A, B, C, D). In contrast, samples 
from the C+ group were mostly intact, and cells were distributed evenly through the 
scaffold (Figure 3E, F). In particular, calcified deposits (Figure 3D) and a cartilage-
like structure (Figure 3F) could be observed in the O+ and C+ scaffolds, respectively. 
No accumulation of cells or matrix was detected in the EMP scaffold (Figure 3G, H). 
Safranin O staining was used to further confirm the cartilage-like structure of the C+ 
group (Figure 4), and showed an abundant glycosaminoglycan content, representing 
the cartilage matrix. Typical chondrocytes were embedded in large lacunae and formed 
isogenous groups (Figure 4B, arrow).
Von Kossa staining was used to test the calcification ability of the cell-scaffold 
constructs after prolonged culture in OM. All samples from the experimental groups 
showed calcified deposits, indicated by black/brown colour (Figure 3I-N), while empty 
scaffolds showed no calcification (Figure 3O, P). Among these groups, the C+ group 
showed the largest positively stained area by visual inspection.
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figure 3 | Representative photomicrographs from different in vitro samples. (A) Overview of 
a sample from the FGF2 group. Note cell accumulation along the scaffold perimeter, and in the 
central areas (HE staining, 5×); (B) High magnification of the framed area in (A) (20×); (C, D) 
overview and detail of the O+ group; (E, F) The C+ group. Note the even cell distribution and 
apparent formation of cartilage-like tissue in the central areas of the scaffold; (G, H) overview and 
detail of the empty control scaffold. Von Kossa staining for cell-scaffold constructs after in vitro 
osteogenic culture. (I) Overview of a sample from the FGF2 group (5×). Note that calcified deposits 
were indicated by black/brown colour; (J) High magnification of the framed area in (I) (20×); (K, L) 
overview and detail of the O+ group; (M, N) overview and detail of the C+ group. Note samples from 
this group showed highest positively stained area by visual inspection; (O, P) overview and detail 
of the empty control scaffold.
figure 4 | In vitro Safranin O staining of C+ group. (A) Abundant GAG (orange-red colour) was 
secreted (5×); (B) higher magnification (20×) of the framed area in (A), typical chondrocytes were 
embedded in large lacunae and formed isogenous groups.
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3.3 Descriptive histology
Two rats died during the surgery, which resulted in the loss of one sample from the 
FGF2 group, one sample from the C+ group, and two samples from the EMP group. 
Post-operatively, all animals showed uneventful recovery and gained weight during 
the 6-week experiment period. No clinical signs of infection or inflammation were 
detected. At euthanasia, visual inspection of the surgical sites showed an undisturbed 
wound healing. After histological processing, 24 out of 28 retrieved samples from 
surgery could be analysed in this study.
 
figure 5 | Histological overview of different treatment groups after 6 weeks of in vivo 
implantation. (A) FGF2 group (HE staining; original magnification 10×); (B) O+ group; (C) C+ 
group; (D) EMP group; (E) higher magnification of the red framed area in (A), new bone formation 
in the scaffold was marked with arrows (EVG staining; original magnification 10×); (F) higher 
magnification of the red framed area in (B), new bone formation deriving from the bone margin 
of the defect (arrow); (G) higher magnification of the red framed area in (C), new bone formation 
at the bottom of the defect, as well as in the scaffold (arrows); (H) higher magnification of the 
red framed area in (D), very limited new bone formation; (I) higher magnification of the blue 
framed area in (A), collagen fibres were attached obliquely to the denuded root surface (Azan 
staining; original magnification 10×); (J) higher magnification of the blue framed area in (B), very 
limited amount of fibres obliquely oriented to the root surface on the coronal side; (K) higher 
magnification of the blue framed area in (C), collagen fibres obliquely oriented to the root surface; 
(L) higher magnification of the blue framed area in (D), obliquely oriented collagen fibres were 
limited to the coronal side of denuded root surface. Scaffolds remnants (marked with *) can be 
found in all groups; D: dentin of the root.
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Light microscopical examination of the sections revealed that the periodontal 
defects could still be distinguished in all samples, as none of the specimens showed 
complete periodontal regeneration. On the apical area of the root surface, a sharp 
dark-stained line between newly formed tissue and old tissue could be observed in 
all groups, indicating the apical end of cementum/ligament removed by the surgery. 
In the defect site, newly formed alveolar bone and ligament could be observed, 
cementum formation was limited to the apical root surface. The fibrous scaffold could 
still be detected, surrounded by multinucleated giant cells, showing an inflammatory 
response to the scaffold remnants. Minor root resorption, dentinoclast-like cells and 
ankylosis could be observed in some specimens. 
In the FGF2 group, more bone was found in the defect area compared to the EMP 
group (Figure 5A and E). The newly formed bone was located in the scaffold or along 
the defect margin. Considering ligament formation, collagen fibres were attached 
obliquely to the coronal root surface. In total, 4/6 of the samples showed collagen 
fibres inserted into the cementum-like tissue layer at the apical end of the defect, while 
between these two parts, collagen fibres ran in parallel to the root surface (Figure 5I).
In the O+ group, more bone was found in the defect area compared to the EMP group, 
mainly initiated from the bone margin of the defects (Figure 5B and F). Along the 
denuded root surface, a thin layer of fibres was observed running parallel to the root 
surface. Only at the coronal side a very limited amount of fibres, obliquely oriented to 
the root surface, were observed (Figure 5J).
In the C+ group, new bone formation was more pronounced compared to the EMP as 
well as FGF2 groups. Newly formed bone was observed at the margin of defect, and 
in 4/6 of the samples, new bone could be detected as islands without direct contact 
with the defect edges (Figure 5C and G). Collagen fibres were attached obliquely to the 
coronal root surface (Figure 5K), and anchored in the newly formed cementum in the 
apical regions (in 5/6 of the samples), while in between, running mostly in parallel to 
the root surface. Cartilage-like tissue could be detected in all samples.
As a control, all specimens in the EMP group showed very limited new bone formation 
(Figure 5D and H). Obliquely oriented collagen fibres were limited to the coronal side 
of denuded root surface (Figure 5L). The defect area was mostly filled with scaffold 
remnants and multinuclear giant cells. 
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figure 6 | Histomorphometrical measurement: (A) relative alveolar height; (B) relative new bone 
area; (C) relative epithelial downgrowth; (D) relative functional ligament length.  
* p < 0.05, ** p < 0.01, *** p < 0.001; error bars represent standard error of the mean (n = 6).
3.4 Histomorphometry and statistical analysis
As shown in Figure 6, the C+ group demonstrated a significantly higher alveolar 
bone height compared to the EMP group. The results of the bone area measurement 
showed that the C+ group had significantly more new bone formation in the defect area 
than the FGF2 and EMP groups. The O+ group also had significantly more new bone 
formation than EMP group. For epithelial downgrowth, no statistical differences were 
found between any of the groups, including the empty control. Finally, for functional 
ligament length, both the FGF2 and C+ groups had significantly higher scores than the 
O+ group. 
4 Discussion 
The overall objective of this study was to explore the most optimal differentiation 
approach for MSCs to achieve periodontal regeneration, using an intra-bony 
periodontal defect rat model. For this purpose, MSCs were seeded on a scaffold and 
pre-cultured in different conditions, i.e. retention of multilineage differentiation 
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potential (FGF2), an osteogenic differentiation approach (O+) and a chondrogenic 
differentiation approach (C+). The in vitro histological results confirmed that cells were 
distributed throughout the scaffolds. Cartilage was formed in the C+ group, and in vitro 
calcification occurred in all experimental groups under osteogenic culture condition. 
The in vivo results demonstrated evident differences. Especially the C+ approach 
resulted in the regeneration of both alveolar bone and periodontal ligament, whereas 
FGF2 only contributed to periodontal ligament regeneration and O+ to alveolar bone 
regeneration. 
Regarding our study design, several remarks can be made. A small animal model was 
applied, whereas a larger animal model would provide higher comparability with 
the human situation (e.g. metabolic rate, defect size) and thus would facilitate the 
translation from bench to bedside. Also, it was inherent to the different differentiation 
protocols, that the culturing time were not equal. As a necessary step for chondrogenic 
differentiation approach, cells were grown in CM for 4 weeks. This longer culturing time 
may influence the performance of C+ samples, although the low serum chondrogenic 
culture condition would principally not stimulate the cell proliferation. Still, it is the 
purpose of this study to compare different approaches for periodontal regeneration. A 
final technical remark should address the scaffold degradation, as in all groups scaffold 
remnants were visible. Thus, it seems necessary to further investigate the degradation 
capacity in vivo. The PLGA/PCL wet-electrospun scaffold is a highly porous scaffold, 
which on beforehand was proved to be suitable for MSC loading and (endochondral) 
bone formation[22]. Still, compared to previous studies using gelatin cell carriers[5], the 
degradation rate of the PLGA-PCL scaffold was much slower, and abundant presence of 
multinucleated giant cells was seen, potentially interfering with new tissue formation. 
Regarding our results in the FGF2 group, only periodontal ligament formation was 
found to be significantly higher than in the O+ group. This corroborates with another 
study, which also showed that bone marrow MSCs can gain characteristics of PDL cells, 
after co-culturing with periodontal ligament-derived cells[24]. However, for bone tissue 
regeneration, the induction from the microenvironment was apparently inadequate.
In the O+ group, the reverse process happened, i.e. only new bone formation was 
seen, but without evident ligament formation. In literature it has been postulated 
that only the establishment of bony support allows the transfer of functional loading, 
which subsequently is important for ligament formation. Thus, it seems likely that the 
time in our current set-up was too short for such a process, and longer time points for 
analyses should be regarded. Alternatively, the lack of ligament formation can be due 
to the induction protocol, using 10 days of osteogenic pre-culture. MSCs at the earlier 
stages have a strong growth potential, but the proliferative capacity decreases when 
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most cells have reached osteogenic differentiation[19,25]. Thus, it can also be argued 
that most cells were already terminally differentiated. As a consequence, proliferation 
rates or differentiation capacity upon implantation were too low to achieve ligament 
formation.
The reason to investigate chondrogenic differentiation is mostly related to cell 
survival. Previous studies were already able to show green fluorescent protein (GFP)-
positive cementoblasts, osteoblasts, osteocytes and fibroblasts in periodontal tissue 
regeneration studies[10]. On the other hand, other recent investigations, tracking GFP-
positive PDL cells in rat calvarial critical-sized defects, underline that cell numbers 
decrease significantly after 4 weeks, with single or no positive cells detectable after 
10 weeks[26]. An enhanced cell survival can explain the positive effects in the current 
C+ group, as chondrocytes are known to be able to survive with limited nutrition and 
oxygen. The C+ group exhibited formation of both hard and soft periodontal tissues, 
which corroborates our earlier findings upon subcutaneous implantation[22]. For the 
effectiveness of the chondrogenic approach, also several other explanations can 
be found in literature. First, the in vitro results showed that C+ samples were more 
resilient to handling due to the large amounts of generated extracellular matrix (ECM) 
after pre-culture. Earlier investigations have shown that such abundant ECM also can 
actively sequester growth factors and cytokines, attract cells from the implant site, 
and thus inherently favours growth and differentiation[27]. Second, the chondrocytes 
produce specific matrix metalloproteinases, initiating remodelling and thus leading 
to mineralization of the hypertrophic cartilage. Finally, the chondrocytes are shown 
to attract blood vessels by releasing VEGF[28], which also could accelerate tissue 
regeneration in the periodontium.
5 Conclusion
Based on our findings, and within the limitations of this study, it can be concluded 
that the chondrogenic differentiation approach is a useful strategy for regeneration 
of alveolar bone and periodontal ligament, in the currently used rat model. Larger 
periodontal defect models and scaffold with higher degradation rate will be necessary 
to examine the full potential of the chondrogenic differentiation approach in 
periodontal regeneration in further investigations. 
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1 Introduction
Current clinical treatment of periodontitis is focusing on the reduction or elimination 
of the periodontal pathogenic condition, merely in order to stop the progression of 
disease[1]. For the regeneration of lost periodontium, a plethora of different techniques 
have been employed, such as guided tissue regeneration (GTR), implantation of 
different bone grafts and/or substitutes, enamel matrix derivative, growth factors 
or various combinations thereof[2]. However, the outcome is still minor and highly 
variable[3]. Recently, several recent studies have focused on the use of cell-based 
tissue engineering strategies for periodontal regeneration[4]. 
For cell-based tissue engineering strategies, primary derived stem cells are expanded 
or conditioned in vitro, then seeded into scaffolds with or without adding biological 
cues. Thereafter, these constructs are implanted into surgical defects to regenerate the 
lost tissue. Our previous study[5] indicated that the chondrogenic differentiation of bone 
marrow stromal cells (BMSCs) after seeding in the scaffold, is a promising strategy to 
regenerate alveolar bone and periodontal ligament in a 3-wall intra-bony periodontal 
defect model in rats, compared with the retention of multilineage differentiation 
potential of BMSCs, and an osteogenic differentiation approach. This approach is based 
on the principle of developmental engineering[6]. During the developmental process of 
long bone and healing of bone fractures, hypertrophic chondrocytes can thrive with 
limited nutrition and oxygen. Blood vessel ingrowth is promoted by secreted vascular 
endothelial growth factor (VEGF)[7] and a mixture of cells is recruited, which results in 
the ossification and vascularization of the cartilage template[8]. 
Despite the favourable application of the chondrogenic differentiation approach in 
periodontal regeneration, this approach is associated with some disadvantages, 
like the low degradation rate of the electrospun poly(lactic-co-glycolic acid)/poly(ε-
caprolactone) (PLGA/PCL) scaffold and the release of acidic degradation products, 
which can potentially interfere with new tissue formation[5]. We hypothesize that 
a gelatin sponge (Spongostan®; Ferrosan Medical Devices, Denmark) with a fast 
degradation rate might be more suitable. Gelatin sponge is a naturally derived and 
clinically applied haemostatic material, which offers excellent biocompatibility, 
biodegradability, and low immunogenicity. The porous structure and hydrophilic 
surface of gelatin sponge allow its use as carrier for the local delivery of cells and 
proteins, which has also been confirmed by previous studies[9-11]. In a recent study by 
our group, this gelatin sponge was successfully applied as a carrier of stromal cell-
derived factor-1α (SDF-1α) in a rat periodontal defect[12]. After 6-week-implantation, it 
was found completely degraded, and no obvious effect of the gelatin sponge on the 
inflammatory response, which corroborates with the other groups[13]. 
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Moreover, since Spongostan® has been used as a hemostatic device in clinic for more 
than two decades, it can eliminate the safety concerns and bridge the translational 
gap between laboratory studies and clinical trials. Investigation on this clinically 
applied gelatin sponge can contribute to the clinical translation of the chondrogenic 
differentiation approach in periodontal regeneration. 
Meanwhile, periodontal ligament (PDL) cells have been reported to possess 
potential to restore the hard as well as soft periodontal tissues[14]. Also, our previous 
study proved that implantation of PDL cells loaded into gelatin sponge can result 
in periodontal regeneration[9]. However, no research has been done to compare the 
efficacies of these two cell-based approaches for periodontal regeneration.  
Therefore, the aim of this study was two-fold: 1) to test the gelatin sponge as a cell 
carrier in periodontal defects in comparison with the electrospun PLGA/PCL scaffold; 
and 2) to compare the regeneration efficacy using PDL cell implantation and BMSC 
chondrogenic differentiation. 
2 Materials and methods
2.1 Fabrication of scaffolds
PLGA (Purasorb® PDLG 5010), PCL (inherent viscosity 1.0-1.3 dl/g) and organic solvent 
2,2,2-trifluoroethanol (TFE; purity ≥ 99.8%) were purchased from Purac Biomaterials 
BV (Gorinchem, the Netherlands), DURECT Corporation (Pelham, AL) and Acros (Geel, 
Belgium), respectively. PLGA/PCL scaffolds were prepared using a wet-electrospinning 
technique as described previously[5]. Disk-shaped scaffolds (Ø 2 mm; thickness 0.6 
mm) were stamped out of the electrospun meshes with a biopsy punch (Kai medical, 
Gifu, Japan) and treated with an ultrasonic processor (UP50H, Hielscher Ultrasonics, 
Germany) in 100% ethanol for 5 min to obtain a very loose structure and greater pore 
size, then sterilized in 70% ethanol for 2 hours.
Commercially available gelatin sponges (Spongostan®) were purchased from Ferrosan 
Medical Devices (Copenhagen, Denmark) and resized to the defect size (2 × 2 × 2 mm3, 
W × L × D). Both electrospun scaffolds and gelatin sponges were subsequently soaked 
in PBS and incubated in basic culture medium (BM, Table 1) overnight at 37 °C.
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table 1  | Cell culture media used in the experiment
Abbreviation Full name Constituents Origin of constituents
BM Basic cell culture 
medium
α-MEM
10% fetal bovine serum (FBS)
100 U/ml penicillin
100 µg/ml streptomycin
Gibco
Sigma
Gibco
Gibco
PM Proliferation 
medium
BM
50 µg/ml L-ascorbic acid
10 nM dexamethasone
Sigma
Sigma
CM Chondrogenic 
medium
high-glucose Dulbecco’s modified 
Eagle’s medium 
 1% FBS
100 U/ml penicillin
100 µg/ml streptomycin
50 µg/ml L-ascorbic acid
100 mM sodium pyruvate 
1:100 insulin-transferrin-selenium 
100 nM dexamethasone
10 ng/ml transforming growth factor 
beta-2 (TGF-β2) 
100 ng/ml bone morphogenetic 
protein 2 (BMP-2)
Gibco
Sigma
Gibco
Gibco
Sigma
Gibco
BD biosciences
Sigma
R&D systems
BD biosciences
 
2.2 Cell isolation, seeding and pre-culture
BMSCs and PDL cells were isolated from 7-week-old male Fischer rats after approval 
from Radboud University Nijmegen Animal Ethics Committee (Approval number: 
RU-DEC 2013-100). The primary cell culture procedure was performed according to 
previous studies[15,16]. BMSCs from passage 2 and PDL cells from passage 4 were used 
for cell seeding.
For cell seeding, electrospun scaffolds and gelatin sponges were soaked in BMSC or 
PDL cell suspension containing 2.0 × 106 cell/ml (10 scaffolds per 1 ml cell suspension) 
and gently rotated for 2 h (Stuart® SB3, Jencons Scientific Ltd., Bedfordshire, UK). Then 
the non-attached cells from the suspension were collected, centrifuged and reseeded 
equally onto each scaffold to ensure highest cell loading efficiency. BM was added 
to each well after 1 h. For the PDL cells seeded group, cell seeding was performed 1 
day before in vivo implantation. For the chondrogenic differentiation groups, the 
constructs were cultured for 1 week in proliferation medium (PM, Table 1). Thereafter, 
the medium was changed to chondrogenic medium (CM, Table 1) culture continued for 
4 weeks, with biweekly medium refreshments[5]. 
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For in vitro assays, haematoxylin and eosin (HE) and Safranin O staining were 
performed to evaluate cell distribution and cartilage formation, respectively. After 
cell seeding and pre-culture, samples were fixed in 10% phosphate-buffered formalin, 
dehydrated in graded ethanol and embedded in paraffin. Following deparaffinization 
in xylene and rehydration through graded ethanol, sections of 6 µm were cut using 
a microtome (Leica RM2165, Nussloch, Germany), and stained with HE or Safranin O 
(n = 5).
2.3 In vivo implantation
After cell seeding and pre-culture, the cell constructs were implanted bilaterally into 
intra-bony three-wall periodontal defects in twelve 7-week-old male Fischer rats (F344/
DuCrl, Charles River, Sulzfeld, Germany). The protocol was approved by Radboud 
University Nijmegen Animal Ethics Committee (Approval number: RU-DEC 2013-100) 
and all procedures were performed in accordance with the national guidelines for the 
care and use of laboratory animals.
table 2 | Group assignment in the animal experiment 
Animal No. Left side Right side
1 PP-C+ GS-C+
2 GS-PDL PP-C+
3 GS-C+ GS-PDL
4 GS-C+ PP-C+
5 GS-C+ GS-PDL
6 GS-C+ PP-C+
7 PP-C+ GS-PDL
8 GS-PDL GS-C+
9 PP-C+ GS-PDL
10 GS-PDL GS-C+
11 PP-C+ GS-C+
12 PP-C+ GS-PDL
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figure 1 | Overview of the surgical procedure and histomorphometry analysis in the rat 
periodontal defect model: (a) preoperative general observation; (b) a full thickness incision was 
made along the alveolar ridge to expose the root surface and alveolar bone; (c) the defect was 
created by using a piezoelectric device (Piezosurgery®, Mectron, Carasco, Italy; loaded with OT5 
B-tip; Ø1.7 mm) to remove the alveolar bone, periodontal ligament and root cementum from 
the root surface, the defect size (W × L × D; 2 × 2 × 1.7 mm3) was constantly checked by a clinical 
periodontal probe; (d) the cell-scaffold construct used in the study; (e) implant placement in the 
defect; (f ) flaps were closed with 5-0 resorbable sutures; (g) schematic drawing illustrating the 
histomorphometry analysis of periodontal tissue regeneration: reference line 1 is drawn based 
on the cemento-enamel junction (CEJ) at the distal portion of first molar; reference line 2 is drawn 
based on the alveolar level of the intact bone; Relative alveolar bone height = L
ac
/L
bg
, where L
ac
 is 
the length of the mesial molar from apex to cusp, and L
bg 
is the length of bone gap, i.e. the distance 
from the regenerated bone level to the normal alveolar bone height level; Relative new bone area = 
A
nb
/A
df
, where A
nb
 is the area of new bone (within yellow frames), and A
df
 is the area of defect (within 
blue frame); Relative epithelial downgrowth = L
je
/L
ac
, where L
je
 is the length of junctional epithelial 
from the CEJ to the apical extent; Relative functional ligament = L
fl
/L
ca
, where L
fl
 is the length of 
functional ligament, and Lca is the distance from the CEJ to the apical end of the defect.
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General inhalation anaesthesia with a mixture of nitrous oxide, isoflurane and oxygen 
was applied during surgery. Pulsoxy and cardiac monitoring was used to ensure that 
an appropriate level of anaesthesia was achieved and maintained. Bilateral intra-bony 
three-wall periodontal defects were prepared mesial at both maxillary first molars[17] 
(Figure 1a-f ). Firstly, a full thickness incision was made along the alveolar ridge mesial 
to the maxillary first molar, then the flaps were raised, and a defect was created along 
the root surface using a piezoelectric device (Piezosurgery®, Mectron, Carasco, Italy; 
equipped with OT5 B-tip; Ø1.7 mm). Afterwards, a less abrasive OP5-tip was used 
to remove the residual alveolar bone, PDL and cementum from the root surface. It 
was also used to finalize the defect (W × L × D; 2 × 2 × 1.7 mm3), with constant size 
monitoring by a clinical periodontal probe. Subsequently, the defects were rinsed with 
sterile saline, dried with sterile gauze. and filled with the constructs randomly (n = 
8): PLGA-PCL electrospun scaffold with chondrogenic differentiation of BMSCs (PP-
C+); gelatin sponge with chondrogenic differentiation of BMSCs (GS-C+) and gelatin 
sponge seeded with PDL cells (GS-PDL). Groups were randomized according to Table 
2. Finally, flaps were repositioned, and sutured with resorbable sutures (Vicryl® 5-0, 
Ethicon Products, Amersfoort, the Netherlands).
2.4 Histological preparation
Six weeks after surgery, rats were sacrificed by CO
2
 suffocation prior to 10% formalin 
cardiovascular perfusion. Complete maxillae were dissected and fixed in buffered 
10% formaldehyde for 24 hours, specimens were decalcified in 10% EDTA, with X-ray 
examination to determine the end point. Afterwards, specimens were dehydrated in 
graded ethanol. Before paraffin embedding, the molars were stained black to ensure 
sections were made in the area of interest. Six-µm-thick sections were cut in mesio-
distal direction with a microtome and every 10th slide was stained with HE for general 
tissue assessment. For ligament, epithelial and bone tissue observation, adjacent 
sections were stained with Azan and Elastica-van Gieson (EVG) staining, respectively. 
The total number of blood vessels in the peri-implant area was determined by 
immunohistochemical staining using an anti-alpha smooth muscle actin (anti-αSMA) 
antibody (1:300 dilutions, Abcam, Cambridge, UK).
2.5 Histomorphometrical analysis
For the quantitative analysis, three sections from the middle third of the defect area 
for each specimen were evaluated. Sections were photographed using a Zeiss Imager 
Z1 equipped with an AxioCam MRc5 camera operated with AxioVision 4.6.3 software 
(Carl Zeiss Microimaging GmbH, Göttingen, Germany). Measurements were performed 
using Image J software by following established methods[12] (Figure 1g).
periodontal regeneration via chondrogenic differentiation approach
97
4
The vascularization was detected with anti-αSMA staining and subsequently digitalized 
by a computer program in the region of interest (ROI; implant + surrounding connective 
tissue). The number of positively stained vascular structures (blood vessels) within 
the ROI were given as percentage (%) of the total area of ROI. For the PP-C+ group, 
vascularization was also analysed by using the ROI without residual scaffold.
2.6 Statistical analysis
Data were expressed as mean ± standard deviation. Statistical analysis was carried out 
using Prism 6.01 (GraphPad Inc, San Diego, CA) by one-way ANOVA and posthoc Tukey 
testing, and differences were considered significant at p < 0.05.
3 Results
3.1 In vitro assays
HE stained sections revealed that cells were distributed evenly throughout the 
scaffolds in all three groups (Figure 2a, c, e). A cartilage-like structure and a large 
amount of extracellular matrix (ECM) were observed in both the PP-C+ and GS-C+ 
groups (Figure 2b, d), whereas no obvious ECM could be found in the GS-PDL group 
(Figure 2f ). The size of samples was similar, even after 5 weeks’ in vitro conditioning for 
the chondrogenic differentiation groups. The residual scaffolds (fibres and sponges) 
were still visible in all samples, and the space in between was larger in the GS-PDL 
group than the other groups.
The cartilage-like structure in the PP-C+ and GS-C+ groups was further confirmed by 
safranin O staining. Abundant glycosaminoglycan content could be detected (Figure 
2g, i), representing the cartilage matrix. The distribution and amount of cartilage 
matrix in the GS-C+ group appeared to be more pronounced than the PP-C+ group. 
Typical chondrocytes were embedded in large lacunae and formed isogenous groups 
(Figure 2h, j).
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figure 2 | Representative photomicrographs of the in vitro samples. (a) Overview of a sample from 
the PP-C+ group. Note the apparent formation of cartilage-like tissue in the scaffold (HE staining, 
5×); (b) High magnification of the framed area in (a) (20×); (c, d) Overview and detail of the GS-C+ 
group. The gelatin sponge is still visible in the sample, and the sample size remains similar after 5 
weeks in vitro conditioning; (e, f ) The GS-PDL group. Note the even cell distribution throughout the 
scaffold. (g) Overview of a sample from the PP-C+ group. Abundant GAG was secreted (orange-red 
colour; Safranin O staining, 5×); (h) Higher magnification (20×) of the framed area in (g), typical 
chondrocytes were embedded in large lacunae and formed isogenous groups; (i) Overview of a 
sample from the GS-C+ group (5×). Note that a larger amount and more even distribution of GAG 
could be observed, compared with the PP-C+ group; (j) High magnification of the framed area in (i) 
(20×); (k, l) Overview and detail of the GS-PDL group.
 
3.2 Descriptive histology
One rat died during the surgery, which resulted in the loss of one sample from the 
PP-C+ group and one sample from the GS-C+ group. All other rats had an uneventful 
recovery and gained weight during the 6-week healing period. No clinical signs of 
infection or inflammation were observed. After histological processing, 19 out of 22 
retrieved samples from surgery could be analyzed in this study.
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figure 3 | Histological overview after 6 weeks of in vivo implantation. (a) PP-C+ group (HE 
staining, original magnification 10×), the periodontal defect was marked with asterisk; (b) GS-C+ 
group; (c) GS-PDL group; (d) higher magnification of the periodontal defect area in (a), new bone 
formation in the scaffold was marked with arrows, the dashed line presents the boundary between 
new bone and old bone (EVG staining; original magnification 10×); (e) higher magnification of 
the periodontal defect area in (b), the defect was fully recovered by newly formed bone (arrows); 
(f ) higher magnification of the periodontal defect area in (c); (g) higher magnification of the root 
surface in (a), limited amount of fibres obliquely oriented to the root surface on the coronal side 
(Azan staining; original magnification 10×); (h) higher magnification of the root surface in (b), 
collagen fibres were attached obliquely to the denuded root surface; (i) higher magnification of the 
root surface in (c). D: dentin of the root.
 
Light microscopical examination of the sections revealed different degrees of 
periodontal regeneration among different groups (Figure 3a, b, c). On the apical 
area of the root surface, a sharp dark-stained line between newly formed tissue and 
old tissue could be observed in all groups, indicating the apical end of cementum/
ligament removed by the surgery. This sharp dark-stained line could also be found 
on the distal side of periodontal defect between newly formed bone and old bone, 
demonstrating the defect margin. In the defect site, newly formed alveolar bone 
and ligament could be observed, cementum formation was limited to the apical root 
surface. A large amount of fibrous scaffold could still be detected in the PP-C+ group, 
surrounded by multinucleated giant cells, showing an inflammatory response to the 
scaffold remnants. In contrast, gelatin sponges were completely degraded, and could 
not be found in the defect region. 
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In the PP-C+ group, relatively less bone was found in the defect area, compared with 
the other two groups. The newly formed bone was mainly located on the bottom of the 
defect, along the defect margin. A large amount of residual scaffold interfered with 
the new bone formation and ligament formation (Figure 3a, d). Considering ligament 
formation, obliquely oriented collagen fibres were limited to the coronal side of 
denuded root surface, the fibres running mostly in parallel to the root surface in the 
other parts (Figure 3g). 
In the GS-C+ group, new bone formation was more pronounced than that in PP-C+ and 
GS-PDL groups. In 3/6 of the samples almost complete regeneration of alveolar bone 
in the defect site was seen. The newly formed bone showed comparable shape with 
the natural alveolar bone along the root surface (Figure 3b, e). Collagen fibres were 
attached obliquely to the denuded root surface, and anchored in the newly formed 
cementum in the apical regions (Figure 3h). The cementum regeneration was limited, 
and only in the apical regions.
In the GS-PDL group, more bone was found in the defect area compared to the PP-C+ 
group, mainly initiated from the bone margin of the defects. The newly formed bone 
showed a different shape with that in the GS-C+ group, where the bone was mainly 
located in the bottom of the defect, but not along the denuded root surface (Figure 3c, 
f ). As to ligament and cementum formation, similar patterns could be found with the 
GS-C+ group (Figure 3i).
3.3 Histomorphometry and statistical analysis
As shown in Figure 4, the GS-C+ group demonstrated a significantly higher alveolar 
bone height than the PP-C+ and GS-PDL groups. There were no statistical differences 
between PP-C+ and GS-PDL. As to the bone area measurement, the GS-C+ and GS-
PDL groups had significantly more new bone formation in the defect area than the 
PP-C+ group. No statistical differences could be detected between all experimental 
groups in epithelial downgrowth. For functional ligament length, the GS-C+ group had 
significantly higher score than the PP-C+ group. 
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figure 4 | Histomorphometrical measurements: (a) relative alveolar height; (b) relative new  
bone area; (c) relative epithelial downgrowth; (d) relative functional ligament length.  
* p < 0.05, ** p < 0.01; error bars represent standard error of the mean (n = 6).
 
figure 5 | Histomorphometrical analysis of vascularization at the periodontal defect site. (a-c) 
Representative photomicrographs from the anti-αSMA staining (original magnification 5×) and 
schematic drawing illustrating the region of interest (ROI; implant + surrounding connective tissue; 
green framed) in PP-C+. GS-C+ and GS-PDL group, respectively; the residual scaffolds in PP-C+ 
group was indicated with red frame in (a); histomorphometrical measurements were performed 
both within the whole defect area (d) and the defect area without the residual scaffolds (e). ** p < 
0.01, *** p < 0.001; error bars represent standard error of the mean (n = 6).
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3.4 Vascularization
Representative images of anti-αSMA stained sections were shown in Figure 5a-c. 
The vascular structures were stained positive in the periodontal defects and the 
surrounding connective tissues. In the PP-C+ group, large amounts of fibrous scaffold 
could still be detected after the 6 weeks experimental period, with apparently limited 
vascularization into the scaffolds. In contrast, all materials were found completely 
degraded in the GS-C+ and GS-PDL groups, with abundant vascularization in the ROI.
Vascularization was further calculated by determining the ROI (both with and without 
the residual scaffolds for PP-C+ group) and the number of positively stained vascular 
structures within this ROI. When calculating within the whole defect area, the GS-C+ 
and GS-PDL groups showed significantly higher score than the PP-C+ group (Figure 5d). 
No statistical differences could be demonstrated among all groups when calculated 
using the ROI without the residual scaffold in PP-C+ group (Figure 5e).
4 Discussion
The overall objective of this study was to enhance periodontal regeneration through 
a chondrogenic differentiation approach by using gelatin sponge, which has a 
relatively faster degradation rate and lower immunogenicity than the PLGA/PCL 
electrospun scaffolds used before. Additionally, the regeneration efficacy using PDL 
cell implantation and BMSC chondrogenic differentiation within the same scaffold 
were compared. For these purposes, BMSCs were seeded into PLGA/PCL electrospun 
scaffolds and gelatin sponges, then pre-cultured in chondrogenic differentiation 
medium for 4 weeks. Meanwhile, PDL cells were seeded into gelatin sponges without 
pre-culture. The in vitro histological results confirmed the even cell distribution 
throughout the scaffolds and characteristic cartilage formation in the chondrogenic 
differentiation groups. Evident differences could be observed from the in vivo results. 
Especially the GS-C+ group showed more prominent regeneration of alveolar bone, 
periodontal ligament and vascularization than the PP-C+ group, whereas GS-PDL 
group showed equivalent new bone area with lower alveolar bone height.
Regarding the scaffolds used in this study, the PLGA/PCL electrospun scaffold is a 
highly porous 3-dimensional (3-D) scaffold fabricated via wet electrospinning, with 
pores among fibres ranging from 3 to 30 µm and porosity about 99.0 ± 0.2%, according 
to our previous studies[5,15]. In contrast, Spongostan® is a commercially available 
gelatin-based porous 3-D scaffold with pore size of 100–300 µm[18]. This larger pore 
size (> 100 µm) was suggested to facilitate cell penetration into the scaffolds and 
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osteoconduction for bone regeneration[19]. Additionally, some signaling peptides of 
collagen might still be retained in gelatin sponges. For example, the Arg–Gly–Asp (RGD) 
sequence can promote cell adhesion, migration and proliferation[20], making gelatin 
sponge a more favourable scaffold in this study. Our in vitro histological analysis 
results do provide further evidence that gelatin sponge supported cell implantation 
and chondrogenic differentiation, through the observation of a large amount of evenly 
distributed cartilage matrix in vitro.
Another significant difference between these scaffolds is the degradation rate. PLGA and 
PCL degrade relatively slow over a few months to a year[21]. The accumulation of acidic 
degradation product (i.e. lactic and glycolic acid) can trigger an inflammatory reaction 
and foreign body response in the defect[22]. In contrast, gelatin sponge degrades much 
faster than PLGA and PCL, where some research groups reported that Spongostan® was 
largely degraded after 6 weeks of in vivo implantation[23,24], but showed good stability 
after 8 weeks’ immersion in PBS[10], which is consistent with our results. In the present 
study, alveolar bone and blood vessels were largely recovered in the defect area of the 
GS-C+ and GS-PDL groups, while the newly formed bone was mainly located along the 
defect margin in the PP-C+ group. These results revealed that the degradation of gelatin 
sponge was balanced to the new bone formation, whereas the slow degradation of 
PLGA/PCL impaired the new bone formation and vascularization in the defect region. 
Moreover, gelatin sponge is known to induce no severe inflammatory reaction or 
other adverse side effects, but involves the multinucleated giant cells activity which is 
responsible for its degradation[11,25]. Therefore, gelatin sponge can be considered as a 
superior scaffold for chondrogenic differentiation approach in periodontal regeneration, 
and may promote the translation of chondrogenic differentiation approach to clinical 
trials or application in the future studies.
As to the successful application of the chondrogenic differentiation approach, several 
remarks can be drawn. Firstly, the chondrocytes can survive with limited nutrition 
and oxygen, which enable them to be functioning during the healing process. Other 
cells, such as BMSCs or PDL cells, were reported to be significantly decreased or even 
un-detectable after in vivo implantation[26-28], which implies that these cells cannot 
survive in that harsh environment, and angiogenic factors or cells are required in those 
approaches. Secondly, recent studies demonstrated that allogeneic chondrogenical 
differentiated BMSCs were non-immunogenic and did not induce the immunogenic 
responses of dendritic cells or activation of destructive T-cell in vitro, while the 
undifferentiated BMSCs implantation into immunocompetent animals did not show 
bone regeneration[29-31]. Thirdly, pro-angiogenic and osteogenic factors were released 
(partially contained in the ECM) by hypertrophic chondrocytes allowing vascularization 
and delivery of osteoblasts to the defect site[32,33]. 
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Interestingly, the GS-C+ and GS-PDL groups showed equivalent new bone area in the 
defect region, but significantly higher alveolar bone height was observed in the GS-
C+ group, indicating more denuded root surface was covered by newly formed bone 
in a physiologically functional manner in this group. This might be due to the active 
remodeling of cartilage template during the hypertrophic stage which confirms the 
rationale that a chondrogenic differentiation approach can lead to a tissue engineered 
“bone organ”, including a physiologically remodeled bone, mature vascular structure, 
and functional hematopoietic microenvironment[34,35]. However, one practical issue 
of chondrogenic differentiation approach is the long pre-culture time (5 weeks in 
this study), which makes this technique difficult to apply for clinical use. Further 
investigations will be needed to optimize this in vitro conditioning process.
5 Conclusions
Based on our findings and within the limitations of this study, it can be concluded that 
gelatin sponge can be used as cell carrier for inducing chondrogenic differentiation of 
BMSCs in vitro, as well as to enhance the regeneration of alveolar bone, periodontal 
ligament and vascularization in vivo through a chondrogenic differentiation approach. 
The chondrogenic differentiation approach using gelatin sponge appears to be a 
promising strategy for periodontal regeneration and has to be developed further for 
translation towards clinical application.
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1 Introduction
Periodontal regeneration has been attempted over the last 30 years. Despite the 
evolution in treatment, the clinical results of periodontal regenerative techniques are 
not optimal and still unpredictable. Currently, the successful application of guided 
tissue regeneration (GTR) with most predictable clinical results is limited to certain 
defect morphology (e.g. two and three-wall intra-bony defects, class II mandibular 
furcation), patient’s characteristics (good oral hygiene, non-smokers) and surgeons’ 
experience (skills, decision-making)[1]. The concept of endogenous cell recruitment can 
be considered as very suitable and appealing for this purpose, particularly, in view of 
modifying the early phase of wound healing, which has been proposed to be the main 
target of future periodontal regenerative technique[2,3]. Increasing evidence in the field 
of regenerative medicine suggests that cell recruitment stimulates latent self-repair 
mechanisms in patients and harnesses the innate capacity for tissue regeneration[4]. 
This strategy has been explored as an alternative to cell-based therapies for in situ 
tissue regeneration of heart, cartilage and bone tissue[5-7]. Instead of introducing ex 
vivo expanded stem cells, recruiting endogenous cells relies on active attraction of 
regenerative cells to a site of tissue damage or injury.
For the periodontium, such a strategy seems very appropriate considering that 
resident mesenchymal stromal cells (MSCs) are regarded as the key for periodontal 
regeneration[2,8]. Additionally, development and clinical application of periodontal cell 
homing technique will mean elimination of constraining factors associated with clinical 
management of periodontal wounds, specific patient and site characteristics. As a 
result, optimal conditions for wound healing that will favour periodontal regeneration 
could become feasible in most clinical settings.
For cell recruitment approaches toward periodontal regeneration, the chemo-
attractant stromal cell-derived factor-1α (SDF-1α) is the primary candidate chemokine. 
SDF-1α plays a major role in cell trafficking and recruitment of CD34+ stem cells[9], and 
several recent periodontal studies have shown the potential of SDF-1α for periodontal 
regeneration[10-12]. As the mechanism underlying this enhanced periodontal 
regeneration, Zhou et al. have found that bone-marrow derived stem cells migrated 
preferentially to the periodontium over other organs to get involved in periodontal 
regeneration[13]. In addition to this cell recruitment efficacy, SDF-1α is anticipated to 
modify the inflammatory response and early wound healing[3,5,14].
Both clinically and experimentally, the haemostatic gelatin-based material 
Spongostan® has been widely used for different applications and as a carrier for 
cells and proteins, respectively[15-17]. Using this material, we here developed a chemo-
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attractive construct and evaluated its feasibility and biological performance in a rat 
periodontal defect model. We hypothesized that this chemo-attractive construct could 
recruit regenerative cells to the periodontal defect site, and hence would improve 
periodontal regeneration (i.e. formation of new alveolar bone, new cementum, and 
new periodontal ligament) compared to defects treated with virgin constructs (i.e. 
without SDF-1α) and empty defects.
2 Materials and Methods
2.1 Material preparation
Commercially available gelatin sponge (Spongostan®; Ferrosan Medical Devices, 
Denmark) was resized to the defect size (2 × 2 × 2 mm3, W × L × D) and loaded via 
absorption with 20 µl PBS solution containing three different doses of recombinant 
human SDF-1α (R&D systems, Abingdon, UK): 100, 200 and 400 ng SDF-1α[12,18]. All 
procedures were done under aseptic conditions.
2.2 In vitro release experiment
SDF-1α (100, 200 and 400 ng) loaded gelatin sponges were incubated in 1 ml PBS 
solution in an Eppendorf tube at 37 °C. At each time point, the complete volume was 
taken and refreshed with 1 ml PBS (n=4). The measurements were performed using an 
ELISA kit (RayBiotech Inc., Norcross GA, US) with a sensitivity of 80 pg/ml according to 
manufacturer’ s instructions.
2.3 Cell culture 
Isolation of GFP cells form 12-week-old GFP-transgenic Sprague-Dawley rats was 
done as described in previous studies by our group[6,15]. It was approved by the Animal 
Ethical Committee of Radboud University (Approval number: RU-DEC 2014-101). This 
study complied with the ARRIVE guidelines for preclinical animal studies. Briefly, two 
femora of each rat were extracted, epiphyses were cut off, and diaphyses were flushed 
out with 15 ml proliferation medium (α-MEM supplemented with 10% FBS and 50 µg/
ml gentamycin). The flush-out of bone marrow from different rats was pooled and 
cultured for 2 days in a humidified incubator (37 °C, 5% CO
2
), after which the medium 
was refreshed to remove non-adherent cells. 
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2.4 Animals & surgery
 
figure 1 | Overview of the surgical procedure: (a) pre-operative surgical site; (b) the root surface 
and alveolar bone were exposed via a 3-mm full thickness incision; (c) a piezoelectric device 
(Piezosurgery®, Mectron, Carasco, Italy; loaded with OT5 B-tip; Ø1.7 mm) was used to create an 
unilateral intra-bony defect, the residual bone, periodontal ligament and root cementum were 
carefully removed from the root surface, to create the defect (W × L × D; 2 × 2 × 1.7 mm3), with 
constant size monitoring by a clinical periodontal probe; (d) the defect size was confirmed by a 
periodontal probe; (e) implant placement in the defect; (f ) the flap was closed with 5-0 resorbable 
sutures.
 
Forty-eight (48) adult male athymic nude rats (Crl: NIH Foxn1rnu, Charles River, 
Germany) were used as experimental animals and recipients of the GFP-transgenic rat 
BMSCs cells to evaluate the biological response to the implants. 
For the creation of standardized and validated rat periodontal defects, a previously 
described surgical protocol was followed[15,16]. As shown in Figure 1, under general 
anesthesia, a unilateral intra-bony defect was created on the mesial side of the first 
maxillary molar. Afterwards, the defect was filled with one of the experimental groups 
in a randomized manner: 1. empty defect (EMP); 2. unloaded sponge (M); 3. SDF-1α 
loaded sponge (SDF). The flaps were closed with resorbable sutures (Vicryl® 5-0; Ethicon 
Products, Amersfoort, the Netherlands). The three different experimental groups (n=8) 
were assigned for evaluation of the biological response after 1 and 6 weeks.
At 2 days after implantation, 1 ml PBS solution containing 1.5 × 106 GFP-transgenic rat 
BMSCs was injected into the tail vein of the rats. During the first 10 post-operative 
days, the animals were fed with powdered food to minimize wound disturbance and 
visual wound inspection was performed on a daily basis.
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2.5  Histological preparation and micro computed tomography (micro-
CT) analysis
After 1 and 6 weeks of implantation, the animals were sacrificed using CO
2
 suffocation. 
The maxillas were harvested and split into two parts through the palatal median 
line. After fixation in buffered 10% formaldehyde for 24 hours, samples were 
decalcified in 4% EDTA at 4°C for 6 weeks, dehydrated with graded series of ethanol 
and embedded in paraffin. Mesio-distal sections (thickness 6 µm) were cut with a 
microtome (Leica RM2165, Nussloch, Germany) and every 10th section was stained 
using haematoxylin and eosin (HE) for general tissue survey. For epithelial, ligament 
and bone tissue observation, sections were stained with Azan and Elastica-van Gieson 
(EVG) staining. For visualization of the GFP positive cells in the defect area, anti-GFP 
immunohistochemical staining was applied (rabbit anti IgG fraction, 1:400, Molecular 
Probes, Eugene, OR, USA). Anti-CD68 staining was used to evaluate the inflammatory 
response. 
After being fixed in 10% buffered formaldehyde for 48 hours, randomly chosen 
complete maxillae (n = 4) were analyzed by micro-CT; 3D-reconstruction of the defect 
areas and volumetric analysis of the newly formed bone was performed as described 
previously[19] (SkyScan 1072, SkyScan N.V., Aartselaar, Belgium). A subregion of the 
originally measured data was selected on both sagittal and transversal slices. This 
selected region of interest (ROI) included the entire defect area with the newly formed 
bone inside. By auto-interpolation of manually determined ROIs from the resliced 
images, each specimen yielded a volume-of-interest (VOI), which served as the 
essential basis for all quantitative analyses. Landmarks, such as intact alveolar bone 
height of the un-operated side and root apex were used for the manual drawing the 
ROI.
2.6 Histomorphometry
For histomorphometrical analysis, three sections per specimen for each of the 
stainings (HE, Azan, EVG, anti-CD68) were evaluated. Measurements were performed 
by using Image J software. All measurements were done as described previously for 
the same periodontal defect model[16]. The relative alveolar bone height, new bone 
area, epithelia downgrowth and functional ligament length were analyzed. The 
inflammatory response (macrophages) was detected with anti-CD68 staining and 
subsequently digitalized by a computer programmer in the ROI (defect area). The 
areas with positive anti-CD68 staining were given as percentage (%) of the total ROI.
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2.7 Statistical analysis
Data were expressed as mean ± standard deviation. Statistical analysis was carried out 
using Graphpad (GraphPad Inc, San Diego, CA, USA) by one-way ANOVA and post hoc 
Tukey testing, for which differences were considered significant at p < 0.05.
3 Results
3.1 In vitro SDF-1α release
Figure 2 shows the release profiles for the constructs loaded with different amounts 
of SDF-1α. For all three loading amounts, a similar release pattern was observed. The 
cumulative released amount of SDF-1α increased gradually up to 35 days, where the 
400 SDF group showed the highest release (338.6 pg). Nevertheless, for all three 
groups, the release of SDF-1α over time was limited in pg compared to loading in ng.
 
figure 2 | Cumulative release profiles of SDF-1α from different groups in 1 ml PBS.
 
3.2 General in vivo observations
All animals had uneventful recovery after surgery and gained weight during the 
experimental period. No signs of infection or clinical inflammation were observed. 
At euthanasia, visual inspection of the surgical sites showed an undisturbed wound 
healing.
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3.3 Micro-CT analysis
Data on new bone formation and 3D reconstructed images of the periodontal defects 
are presented in Figure 3. After 1 week, defect areas were easily detected, and minor 
bone formation was observed predominantly at the defect edges in all experimental 
groups. After 6 weeks, EMP showed limited new bone formation, whereas more newly 
formed bone was observed for M and SDF.
 
figure 3 | (a) 3D reconstructed micro-CT images of periodontal defects with different groups after 
1 and 6 weeks: empty control (EMP); unloaded material (M); SDF-1α loaded gelatin sponge (SDF). 
Black asterisk indicates the position of the molar. (b) The histogram below represents the percentage 
of bone volume to tissue volume of different groups at week 1 and 6.
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The volumes of the newly formed bone at week 1 were similar (1%) for all groups (p > 
0.05). After 6 weeks, all groups presented a significant increase in the amount of new 
bone formation (6.8%, 9.6% and 17.1%, respectively); SDF showed significantly higher 
new bone formation compared to EMP (p < 0.01) and M (p < 0.05). Only for SDF, bone 
ingrowth from the bottom of the defect was observed.
 
figure 4 | Histological overview after 1 week of implantation. (a) EMP group (HE staining; original 
magnification 10×), no obvious periodontal regeneration could be observed; (b) M group, scaffold 
remnants could be found in the defect site; (c) SDF group, scaffold remnants could also be found; 
Black asterisk indicates the defect site. (d) higher magnification of the defect site in (a), positive 
staining could be found in the whole defect area (anti-CD68 staining; original magnification 10×); 
(e) higher magnification of the defect site in (b); (f ) higher magnification of the defect site in (c), 
relatively less positive staining could be found in the defect area.
 
3.4 Descriptive histology
3.4.1 One-week results
After 1 week, the defects were easily detected by the removed cementum from the 
root surface and absence of supportive alveolar bone. This occasionally resulted 
in penetration into the glands apically (Figure 4a-c). For M and SDF, the implanted 
material was found in place with hardly any signs of degradation, and surrounded 
by thin fibrous tissue capsule. Above them sub-epithelial inflammatory infiltrate 
was found (Figure 4d-f ). For EMP, the defects were filled with connective tissue and 
immense inflammatory infiltrate. Besides the presence of extensive inflammation, 
other common findings observed in all groups were epithelial downgrowth (to the level 
to which the cementum was removed), minor start of bone formation from the defect 
edges and no signs of PDL formation or cementum formation.
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figure 5 | Histological overview after 6 weeks of implantation. (a) EMP group (HE staining; 
original magnification 10×); (b) M group; (c) SDF group; (d) higher magnification of the defect 
area in (a), new bone formation in the defect was marked with arrows, the dash line present the 
boundary between new bone and old bone (EVG staining; original magnification 10×); (e) higher 
magnification of the defect area in (b), new bone formation deriving from the bone margin of the 
defect (arrow); (f ) higher magnification of the defect area in (c), the defect site was fully recovered 
by new bone formation (arrow); (g) higher magnification of the root surface in (a), collagen fibres 
were attached obliquely to the denuded root surface (Azan staining; original magnification 10×); 
(h) higher magnification of the root surface in (b), very limited amount of fibres obliquely oriented 
to the root surface on the coronal side; (i) higher magnification of the root surface in (c), collagen 
fibres obliquely oriented to the root surface; (j) higher magnification of the defect area in (a), 
positive staining could be found in the defect area (anti-CD68 staining; original magnification 10×); 
(k) higher magnification of the defect area in (b); (l) higher magnification of the defect area in (c), 
almost on positive staining could be found in the defect area. Black asterisk indicates the defect 
site; D: dentin of the root.
 
3.4.2 Six-week results
After 6 weeks, the edges of the periodontal defects were still visible. All materials were 
found completely degraded, and the inflammatory infiltrate in the defect region was 
considerably reduced (Figure 5a-c). For SDF, bone formation was more pronounced 
than for EMP and M, and in 3/8 of samples the alveolar bone in the defect area was 
completely regenerated (Figure 5d-f ). Epithelial downgrowth remained at the same 
level as at week 1, with no obvious differences among the experimental groups, 
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which proves that a barrier membrane is not required to prevent soft tissue ingrowth. 
As such, we opted to leave out a barrier membrane in the current study. Limited 
formation of periodontal ligament with new cementum and new bone was observed, 
which was significant in SDF compared to the other two groups (Figure 5g-i). For the 
pan-macrophage anti-CD68 staining, an evident decrease of inflammatory response 
was observed for all experimental groups compared to week 1. SDF demonstrated a 
significantly lower level of inflammatory response compared to EMP and M (Figure 
5j-l). In addition, anti-GFP staining was performed to track the recruitment of GFP-
positive rat BMSCs to the periodontal defect in vivo, but no positive result could be 
obtained for all groups (data not shown).
3.5 Histomorphometry
For alveolar bone height, a substantial increase with time was observed in all groups 
(Figure 6). The SDF demonstrated a significantly higher alveolar bone height compared 
to the EMP and M at week 6 (p < 0.01), with no statistical difference among all groups 
at week 1 (p > 0.05), which was in accordance with the micro-CT results. Similar results 
could also be found in the bone area measurement, where the SDF had significantly 
more new bone formation in the defect area than the M at week 6 (p < 0.05). For the 
epithelial downgrowth, no statistical difference could be found among all groups at 
both week 1 and week 6 (p > 0.05). As to the functional ligament length, the SDF had 
significantly higher score than the M at week 6 (p < 0.05), with no statistical difference 
among all groups at week 1 (p > 0.05). Although the SDF had higher scores than the EMP 
in the new bone area and functional ligament measurements at week 6, no statistical 
difference had been obtained between them (p > 0.05). Finally, for the inflammatory 
response, it was around 28% for all groups at week 1, with no statistical difference 
among them (p > 0.05). At week 6, the SDF (7.7%) showed significantly lower level of 
inflammatory response than the M (14.8%, p < 0.05), with no statistical difference to 
the EMP (11.8%, p > 0.05).
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figure 6 | Histomorphometrical measurement at week 1 and 6: (a, b) relative alveolar height; (c, 
d) relative new bone area; (e, f ) relative epithelial down-growth; (g, h) relative functional ligament 
length; (i, j) relative amount of inflammation in percentage for all evaluation periods.  
*p < 0.05, **p < 0.01; error bars represent standard error of the mean (n = 8).
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4 Discussion
The objective of this study was to develop a construct for periodontal regeneration 
based on cell recruitment using SDF- 1α, and to evaluate the feasibility and biological 
performance of this construct. The results showed that SDF-1α constructs significantly 
improved periodontal wound healing at week 6 in terms of alveolar bone height, new 
bone area, and functional ligament length. However, in vitro release of SDF from the 
scaffold was suboptimal.
Our in vitro release results corroborate those of Takayama et al, whose used a collagen 
membrane as a carrier for SDF-1α with only 10% SDF-1α release after 3 weeks[20]. In our 
study, also limited amount of SDF-1α was released in vitro up to 35 days. The most part 
of SDF-1α remained absorbed on the gelatin sponge, or deactivated during the test. 
It seems that the bonding force between SDF-1α and gelatin/collagen might be too 
strong, and/or physical adsorption of SDF-1α on the gelatin sponge (Spongostan®) is 
not an efficient approach for SDF-1α delivery. It has to be noticed that, Spongostan® is 
a commercial product, and besides gelatin the rest of its components are unknown. 
Other carriers, such as a hydrogel[21], PLGA[22], alginate[23] and radially oriented collagen 
scaffold[14] have been utilized with various success to continuously deliver SDF-1α to 
accelerate blood vessel, cartilage and bone regeneration. More extensive research 
with other carriers (such as polymer scaffolds) for SDF-1α delivery, or using gene 
transduction approaches to up-regulate SDF-1α expression should be explored in the 
future.
Despite the suboptimal in vitro release of SDF-1α from the scaffold, the SDF-1α 
construct significantly increased new bone formation in rat periodontal defect after 
6 weeks of implantation. This effect was not found after 1 week of implantation, and 
this could be explained with the retention of SDF-1α within the scaffold. After 6 weeks 
the gelatin was found completely degraded within our defect, and obviously during 
this degradation process SDF-1α was released and managed to exert its effect. Our 
histomorphomterical and micro-CT results are in accordance with a previous study 
made by our group[6], in which a 6-fold increase in bone formation was observed in a 
SDF-1α mediated GBR procedure. Takayama et al. applied a SDF-1α loaded collagen 
membrane in a rat mandibular bone defect model, and got similar results to our 
findings on the positive effect of SDF-1α on bone formation[20]. Their micro-CT analysis 
showed similar amounts of new formed bone (i.e. volume and area) as in our study. 
Although they used a model for bone augmentation, different scaffold (i.e. collagen 
membrane), higher doses of SDF-1α (3 and 6 µg) and implantation period of 4 weeks, 
the results were still comparable.
chapter 5
122
Similar to the new bone formation, the SDF-1α group also demonstrated significantly 
longer functional ligament length than the unloaded group after 6 weeks of 
implantation. This finding is in accordance with other studies that utilize SDF-
1α incorporated collagen membrane[10], endochondral approach[16] or PDL cells 
implantation with gelatin sponge[15] to regenerate periodontium. In these studies, the 
regeneration of periodontal ligament as well as alveolar bone could be detected. It can 
even be hypothesized that the processes of bone and ligament formation are related 
to each other, similar to the development of the natural periodontium during teeth 
eruption.
Regarding our experimental design, no barrier membrane was included, which was 
widely used in the traditional GTR procedure. Based on our previous work[15,16], gelatin 
sponge and electrospun scaffolds have been successfully applied in rat periodontal 
defect without the use of barrier membranes and showing evident periodontal 
regeneration. Moreover, no significant differences in epithelial downgrowth were 
observed among experimental groups at different time points, which proves that a 
barrier membrane is not required to prevent soft tissue ingrowth. As such, we opted to 
leave out a barrier membrane in the current study.
For the in vivo rat BMSCs recruitment test, no GFP-positive rat BMSCs could be found in 
the periodontal defect area. This might be explained by the slow degradation of gelatin 
sponge in vivo, which resulted in the very delayed release of SDF-1α, and/or by the low 
dose of SDF-1α used. This mismatched time line might result in the immobilization of 
GFP-positive cell in the other organs rather than the periodontal defect. Similar result 
had also been reported by another research group[24]. However, other studies using 
constructs with burst release of SDF-1α in the early stage demonstrated successfully 
the recruitment of BMSCs[6,25,26]. Therefore, further investigation is needed to confirm 
the recruitment of GFP-positive rat BMSCs in the periodontal defect, and higher dose 
of SDF-1α might be considered. 
The enhanced periodontal regeneration in response to local SDF-1α stimuli could be 
explained such as follows. Firstly, the bone marrow-derived osteoblast progenitor cells 
existed in the circulating blood, might be recruited to the defect site in response to 
local release of SDF-1α via SDF-1α/CXCR4 axis[6,27]. Those recruited cells contributed to 
the periodontal healing process by not only exerting their multi-lineage differentiation 
capacity in the defect site, but also secreting a number of cytokines and growth factors 
to promote tissue regeneration[28]. Secondly, the local release of SDF-1α might also 
generate proangiogenic environment in the defect site by mobilizing other progenitor 
cells resident in bone marrow, such as hematopoietic stem cell (HSC) and endothelial 
progenitor cell (EPC), to the defect site through SDF-1α/CXCR4 axis[29,30]. Those cells 
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could have enhanced angiogenesis in the defect area, hence indirectly enhancing 
periodontal regeneration. The effect of SDF-1α on angiogenesis was not investigated 
in our study as a haemostatic material (i.e. Spongostan) was used for its delivery 
into the defect. However, this mechanism should be explored when SDF-1α is further 
investigated with a more suitable scaffold for periodontal regeneration.
Regarding the inflammatory response, the SDF showed significantly lower 
inflammatory response than the M at week 6. Inhibitory effect on inflammation of SDF-
1α was also seen in other studies. Thevenot et al reported that SDF-1α could reduce 
but not reverse the inflammatory responses[22]. There was a substantial decrease 
in density and activation of mast cells and inflammatory (CD11b+) cells in the space 
surrounding the SDF-1-loaded PLGA scaffold in mice. Meanwhile, in a rat mandibular 
bone defect, SDF-1α significantly reduced the CD11b+ inflammatory cell response[31].
5 Conclusion
Based on our findings, and within the limitations of this study, it can be concluded 
that the chemo-attractive constructs significantly improve periodontal wound healing 
at 6 weeks in terms of alveolar bone height, new bone area, and functional ligament 
length. Chemo-attractive constructs based on SDF-1α were proven effective, and 
should be considered for further development towards clinical use, in the treatment 
of periodontology.
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1 Summary and address to the aims
Thanks to social progress and recent advances in medical science, a prolonged life 
span has been achieved in the general population. Simultaneously, maintenance of 
the natural dentition becomes more important for the general health and quality of 
life. However, the growing average age is associated with an increase in the occurrence 
of periodontal disease, which can eventually result in the loos of teeth, and even the 
whole dentition[1,2]. Therefore, effective solutions, such as predictable regeneration of 
periodontium to its original state and function, are of urgent need. Various treatment 
procedures have been adopted to achieve periodontal regeneration, including scaling 
and root planing, open flap debridement, guided tissue regeneration, the application 
of bone grafts and/or substitutes, and local application of growth factors. However, all 
these procedures have limitations in achieving complete periodontal regeneration[3]. 
Due to recent scientific advances, tissue engineering provides a promising approach 
for periodontal regeneration. The use of cells, scaffolds and signalling molecules can 
provide a construct that facilitates the periodontal healing process in an ordered and 
programmed sequence, both temporally and spatially, and corresponds to in vivo 
developmental stages[4].
The aim of the current thesis was to investigate cell-based tissue engineering strategies 
for periodontal regeneration. In chapter 1, a general introduction on periodontal tissue 
engineering and a description of the aims of this thesis are presented. Thereafter, each 
following chapter discusses a separate research question. This summary addresses 
the aims as described in chapter 1 in successive order:
1  Is the co-culture of postnatal dental mesenchymal cells and dental epithelial cells 
in 3-dimensional (3-D) porous electrospun scaffolds a suitable approach for dental 
tissue engineering?
In chapter 2, we investigated the use of three-dimensional electrospun poly(lactic-co-
glycolic acid)/poly(ε-caprolactone) (PLGA/PCL) scaffolds seeded and cultured with 
postnatal dental cells, for improved dental tissue regeneration. Wet-electrospinning 
combined with ultrasonic treatment was studied as a method to enhance scaffold 
porosity and to promote cell-cell interactions. We also investigated whether nano-
hydroxyapatite (nHA) incorporation enhanced dental cell differentiation. All scaffolds 
were seeded with human tooth pulp-derived dental mesenchymal (DM) cells, or 
a combination of DM and pig dental epithelial (DE) cells, cultured for up to 28 days. 
Developmentally staged samples were assessed using scanning electron microscopy, 
histological, immunohistochemical, DNA and alkaline phosphatase activity assays, 
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and quantitative-PCR for ameloblastic, odontoblastic, and osteogenic related gene 
expression. Results showed that electrospun scaffolds exhibited enough porosity 
to support robust cell ingrowth. Additional ultrasonic treatment led to a less 
homogeneous scaffold porosity, resulting in evident cell clustering and enhanced DM-
DE cell-cell interactions. Finally, nHA incorporation was found to enhance dental cell 
differentiation. However, it also resulted in smaller fibre diameter and reduced scaffold 
porosity, and inhibited cell ingrowth and proliferation. 
In conclusion, ultrasonically treated wet-electrospun PLGA/PCL scaffolds are a 
suitable material for dental tissue engineering, and support future in vivo evaluations 
of this model.
2  Which differentiation approach of bone marrow stromal cells (BMSCs) before 
implantation is favourable for periodontal regeneration?
The implantation of BMSCs has previously been shown promising to achieve 
periodontal regeneration. However, the preferred pre-implantation differentiation 
strategy (e.g. maintenance of stemness, osteogenic or chondrogenic induction) to 
obtain optimal periodontal regeneration is still unknown. In chapter 3, the most 
suitable differentiation approach for periodontal regeneration was explored. MSCs 
were obtained from Fischer rats and seeded onto poly(lactic-co-glycolic acid)/
poly(ε-caprolactone) electrospun scaffolds, and then pre-cultured under different in 
vitro conditions: a. retention of multilineage differentiation potential; b. osteogenic 
differentiation approach; and c. chondrogenic differentiation approach. Subsequently, 
the cell-scaffold constructs were implanted into experimental periodontal defects 
of Fischer rats, with empty scaffolds as controls. After 6 weeks of implantation, 
histomorphometrical analyses were applied to evaluate the regenerated periodontal 
tissues. The chondrogenic differentiation approach showed regeneration of alveolar 
bone and ligament tissues. The retention of multilineage differentiation potential 
supported only ligament regeneration, while the osteogenic differentiation approach 
boosted alveolar bone regeneration.
Based on the results, we concluded that chondrogenic differentiation of MSCs before 
implantation is a useful strategy for regeneration of alveolar bone and periodontal 
ligament, in the currently used rat model.
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3  Can enhanced periodontal regeneration through a chondrogenic differentiation 
approach be achieved by using a gelatin sponge, which has a relatively faster 
degradation rate and lower immunogenicity than a previously applied PLGA/PCL 
electrospun scaffold?
The previous study in chapter 3 demonstrated that chondrogenic differentiation 
of BMSCs before implantation can support periodontal regeneration, but the 
slow degradation rate and acidic degradation products of poly(lactic-co-glycolic 
acid)/poly(ε-caprolactone) (PLGA/PCL) electrospun scaffold showed limitations. 
Therefore, in chapter 4, gelatin sponge, which exhibits a faster degradation rate 
and lower immunogenicity, was employed to enhance periodontal regeneration. 
The regeneration efficacy using PDL cell implantation and BMSC chondrogenic 
differentiation added to gelatin sponge were compared. BMSCs were obtained from 
Fischer rats and seeded into PLGA/PCL electrospun scaffolds and gelatin sponges, 
then pre-cultured in chondrogenic differentiation medium. In addition, PDL cell 
loaded gelatin sponges were used. Subsequently, these constructs were implanted 
for 6 weeks into periodontal defects created in Fischer rats. Periodontal regeneration 
was evaluated by histomorphometrical analyses. The chondrogenic differentiation 
approach using gelatin sponge showed more prominent regeneration of alveolar bone, 
periodontal ligament and vascularization than using PLGA/PCL scaffolds, whereas PDL 
cell implantation led to equivalent new bone area with lower alveolar bone height.
In conclusion, gelatin sponge can be used as cell carrier for inducing chondrogenic 
differentiation of BMSCs in vitro, as well as enhance periodontal regeneration through 
a chondrogenic differentiation approach.
4  Can a cell homing approach using gelatin sponge as scaffold be an alternative 
strategy for periodontal regeneration instead of cell implantation approaches?
Chemo-attractants, such as SDF-1α, can offer an advantage for periodontal regeneration 
by recruiting the patient’s own stem cells to stimulate self-repair. In chapter 5, we 
developed a chemo-attractive construct for periodontal regeneration using SDF-1α and 
evaluated its efficacy in vivo. SDF-1α was loaded on gelatin sponge and tested in vitro for 
SDF-1α release. Subsequently, SDF-1α constructs were implanted into rat periodontal 
defects for 1 and 6 weeks, with unloaded materials and empty defects as controls. The 
regenerative efficacy was evaluated by micro-CT, histological and histomorphometrical 
analyses. In vitro results showed limited SDF-1α release up to 35 days. In contrast, 
SDF-1α constructs significantly improved periodontal defect regeneration in terms of 
alveolar bone height, new bone area, and functional ligament length. Additionally, SDF-
1α constructs decreased the inflammatory response at week 6.
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In this chapter, chemo-attractive constructs significantly improved periodontal 
regeneration in terms of alveolar bone height, new bone area, and functional ligament 
length, and should be considered for further development towards clinical use, in the 
treatment of periodontology.
2 Closing remarks and future perspectives
This thesis aimed to develop cell-based tissue engineering strategies for periodontal 
regeneration. Results confirmed that cell-based strategies are promising approaches 
to regenerate dental tissues and that they offer potential for further development into 
application in clinical periodontology. Firstly, in chapter 2, human tooth pulp-derived 
dental mesenchymal (DM) cells and pig dental epithelial (DE) cells were seeded 
into three-dimensional electrospun PLGA/PCL scaffolds in order to regenerate the 
tooth organ (including the periodontal tissue). The results indicated that evident cell 
clustering and enhanced DM-DE cell-cell interactions, which is essential for tooth 
development, could be induced by the ultrasonically treated wet-electrospun PLGA/
PCL scaffolds. The material was found to be suitable for dental tissue engineering, and 
the result supports future in vivo evaluation of this strategy. Secondly, in chapter 3, a 
chondrogenic differentiation approach of BMSCs using the same scaffolds as in chapter 
2 was proposed for periodontal regeneration. Results demonstrated that this approach 
can support regeneration of alveolar bone and ligament tissues in the intra-bony 3-wall 
periodontal defect in rat. However, the slow degradation rate and acidic degradation 
products of PLGA/PCL electrospun scaffold can potentially interfere with new tissue 
formation. Therefore, in chapter 4, a gelatin sponge, which exhibits a faster degradation 
rate and lower immunogenicity, was employed to enhance periodontal regeneration 
through the chondrogenic differentiation approach of BMSCs. Results confirmed the 
enhanced regeneration effect, and suggested the feasibility of clinical translation 
for this approach. Thirdly, in chapter 5, a cell homing approach was introduced to 
periodontal regeneration. Gelatin sponge loaded with SDF-1α significantly improved 
periodontal defect regeneration in terms of alveolar bone height, new bone area, and 
functional ligament length, compared with the bare scaffold and empty control groups. 
Nevertheless, a lot of questions have still to be answered before this technology 
can indeed be applied. First, it is important to bear in mind that all the conclusions 
generated in this thesis have been obtained from cell culture and animal experiments, 
which cannot always be directly translated to the human situation. In this thesis, a 
surgically created intra-bony 3-wall periodontal defect in the maxillary first molar of rat 
was used to evaluate the regenerative effect of different cell-based tissue engineering 
strategies. However, the periodontium is chronically exposed to a dysbiotic microbial 
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community, and the defects are always presented in various forms and compromised 
anatomy (horizontal or vertical bone defects, one-wall, two-wall, three-wall defects, 
furcation defects, etc.)[5]. Therefore, we do not know how this lack of a microbial origin of 
the experimental defects affects the outcome of our studies. There are several murine 
models available in which periodontal disease is initiated by microbial induction, but 
this is still not similar to the cause and progress of as periodontal disease in humans. 
Consequently, either new approaches (i.e. lab-on-a chip, high throughput, etc.) or new 
animal models must be developed that show better similarity to the initiation and 
progress of periodontal disease in humans.
Next, for successful cell-based approaches, it is important to develop strategies 
that enable the survival of the implanted cells. Although, it has been described that 
BMSCs implanted into a periodontal defect can survive and promote the regeneration 
of periodontal tissue[6], a more recent study contradicts this finding[7]. This experiment 
involved the tracking of transplanted GFP-positive PDL cells in rat critical-sized 
calvarial defects and showed that cell numbers decreased significantly after 
4 weeks, with single or no positive cells detectable after 10 weeks, which indicates 
that transplanted cells “vanished” after implantation. A reason for the disappearance 
of cells is the lack of vascularization of the implanted construct. Therefore, a possible 
approach is the stimulation of vascularization by co-culturing with angiogenic cells or 
incorporation of angiogenic factors. Another method is the currently used chondrogenic 
differentiation approach, as chondrocytes are known to be able to survive with limited 
nutrition and oxygen, and secrete VEGF to promote blood vessel ingrowth. 
High cell density is crucial for the formation of cartilage templates in vitro. Due to the 
limits of cell source and long-term in vitro cell conditioning (5 weeks in the current 
studies), the clinical translation of this chondrogenic differentiation approach by 
using autologous cells is challenging. Therefore, the use of easier accessible stem cell 
types should be considered, such as mesenchymal stem cells derived from adipose 
tissue or gingival tissue. Moreover, a recent attempt to use cell-free extracellular 
matrix in the chondrogenic differentiation approach offers a new way to overcome 
the current limitations[8]. For example, scaffolds can be used, which release various 
biological cues at the right timing. These cues then provoke a host cell performance 
to target endochondral bone formation and periodontal regeneration, even without 
implantation of exogenous cells. More importantly, the underlying mechanism involved 
in the processes of in vitro chondrogenic differentiation and periodontal regeneration 
after the implantation of a cartilage template needs further investigation. Only after 
the cellular and molecular events involved in these processes are fully elucidated, a 
reliable chondrogenic differentiation approach can be further simplified and more 
effectively applied in the clinic. 
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Although, the cell homing strategy achieved favourable periodontal regeneration in 
the present study, in vitro release of SDF-1α from the gelatin sponge was suboptimal[9]. 
More extensive research with other carriers (such as polymer scaffolds) for SDF-
1α delivery, or even using gene transduction approaches to up-regulate SDF-1α 
expression, must be explored in the future. Also, the scaffold design needs to be 
modified to control the SDF-1α delivery in a specific spatial and temporal order, e.g. 
the release sequence in different locations (root surface, alveolar bone site, and the 
space in between) should be determined and coupled to the regenerative process of 
the different periodontal tissues.
In summary, recent advances in the knowledge of cell biology, material sciences and 
biomolecules provide exciting opportunities for clinical translation of novel dental 
tissue engineering strategies. However, before complete periodontal regeneration 
can be introduced in periodontal clinics, further studies are required to modify the 
scaffold design to modulate DM-DE cell-cell interaction, to optimize the chondrogenic 
differentiation approach and to accelerate the in vitro conditioning process, to 
control the SDF-1α delivery in a specific spatial and temporal order, to investigate the 
underlying cellular and molecular mechanisms in the periodontal regeneration process 
as well as to develop alternative models that mimic periodontal disease in humans.
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1 Samenvatting en doelstellingen
Dankzij maatschappelijke en medische vooruitgang, loopt de gemiddelde 
levensduur van de bevolking langzaam op. Tegelijkertijd wordt het behouden van 
het natuurlijke gebit belangrijker voor de algemene gezondheid en de kwaliteit van 
leven. De toenemende gemiddelde leeftijd is echter geassocieerd aan een toename 
van parodontale aandoeningen, die uiteindelijk kunnen leiden tot het verlies van 
tanden, of zelfs van het hele gebit[1,2]. Daarom zijn er snel effectieve oplossingen 
nodig die kunnen zorgen voor een voorspelbare regeneratie van het parodontium 
tot aan de originele staat en functie. Verschillende behandelingen worden gebruikt 
om parodontaal herstel te bewerkstelligen, zoals een grondige sub-gingivale 
reiniging, een flapoperatie, geleide weefsel regeneratie, het toepassen van bot of 
botsubstituten, en de locale toediening van groeifactoren. Alle dergelijke procedures 
kennen echter beperkingen en leiden niet tot compleet parodontaal herstel[3]. Door 
wetenschappelijke vooruitgang op het gebied van weefselregeneratie, ontstaan 
er op dit moment echter nieuwe veelbelovende aanpakken. Met behulp van cellen, 
dragermaterialen en signaalmoleculen kan een construct gemaakt worden om 
parodontale genezing op een ordelijke en vooraf voorspelbare manier mogelijk te 
maken, zowel qua tijd als qua vorm, en in overeenstemming met de natuurlijke fasen 
van ontwikkeling[4].
Het doel van het huidige proefschrift was dan ook onderzoek te doen naar een (op 
cellen gebaseerde) weefsel regeneratie aanpak voor het parodontium. In hoofdstuk 
1, wordt een algemene inleiding gegeven over parodontale weefselregeneratie, 
en worden de doelstellingen van de thesis gepresenteerd. Elk volgend hoofdstuk 
bespreekt een afzonderlijke onderzoeksvraag. Deze samenvatting behandelt de 
vragen uit hoofdstuk 1 achtereenvolgens:
1  Is een co-kweek van postnatale dentale mesenchymale cellen met dentale 
epitheliale cellen, in een 3-dimentionale (3-D) poreuze drager gemaakt met 
electrospinnen, een geschikte aanpak voor dentale weefselregeneratie ?
In hoofdstuk 2, werd het gebruik van een 3D poly(melkglycolzuur)/poly(ε-caprolacton) 
(PLGA/PCL) dragermateriaal beschouwd, dat was ingezaaid met postnatale 
dentale cellen. Electrospinnen onder vochtige omstandigheden, in combinatie met 
ultrasonificatie, werd daarbij bestudeerd als een methode om de porositeit van de 
drager te verhogen en om cel-cel interacties te bevorderen. Er werd vervolgens ook 
nog onderzocht of het toevoegen van nano-hydroxyapatiet (nHA) de differentiatie 
van de cellen bevorderde. Alle dragers werden geladen met mesenchymale (DM) 
cellen uit humane pulpa, of de combinatie van DM en varkens dentale epitheliale 
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(DE) cellen, en vervolgens opgekweekt gedurende 28 dagen. Tijdens verschillende 
ontwikkelingsstadia werden de kweken beschouwd met behulp van scanning 
elektronenmicroscopie, histologie, immunohistochemie, DNA- en alkalische 
fosfataseactiviteit testen, en kwantitatieve-PCR voor ameloblaste-, odontoblaste-, 
en ostegene genexpressie. De resultaten lieten zien dat de dragermaterialen poreus 
genoeg waren voor celingroei. De ultrasone behandeling leidde tot een minder 
homogene porositeit, wat resulteerde in het clusteren van cellen, en verbeteren 
van de interactie tussen de DM en DE cellen. Het toevoegen van nHA had tenslotte 
een verhoogde celdifferentiatie tot gevolg, maar leidde tegelijkertijd tot een lagere 
vezeldiameter en afgenomen porositeit, waardoor celingroei juist weer verminderde. 
In conclusie kan gezegd worden dat ultrasoon behandelde PLGA/PCL dragers, die 
gemaakt zijn door middel van met electrospinnen onder vochtige omstandigheden, 
geschikt zijn als dragermateriaal voor tandheelkundige weefselregeneratie, en dat 
toekomstige in vivo evaluatie van dit model ondersteund wordt.  
2  Welke aanpak voor de differentiatie van stromale cellen verkregen uit beenmerg 
(BMSCs), voorafgaand aan implantatie, is het best geschikt voor parodontale 
regeneratie?
Het implanteren van BMSCs is al bekend als een veelbelovende aanpak om 
parodontale regeneratie te bewerkstelligen. De meest geschikte strategie voor 
celdifferentiatie voorafgaand aan implantatie is echter onbekend (dwz. het behouden 
van de stamceleigenschappen, osteogene-, of chondrogene inductie). In hoofdstuk 
3, werd dus de meest geschikte aanpak voor differentiatie beschouwd. BMSCs 
werden verkregen uit Fischer ratten, en ingezaaid op poly(melk-glycolzuur)/poly(×-
caprolacton) dragermaterialen, en vervolgens voorgekweekt onder verschillende 
in vitro omstandigheden: a. behoud van het brede differentiatiepotentiaal; b. 
osteogene differentiatie; en c. chondrogene differentiatie. Vervolgens werden de cel-
dragermateriaal constructen geïmplanteerd in kunstmatige parodontale defecten 
bij Fischer ratten, waarbij lege dragers dienst deden als controles. Na 6 weken van 
implantatie, werden histomorphometrische analysen toegepast om het regenererend 
parodontium te bekijken. De aanpak met chondrogene differentiatie liet regeneratie 
zien van zowel het alveolaire bot als van de ligament weefsels. Het behouden van het 
differentiatiepotentiaal leidde alleen tot regeneratie van ligament, terwijl osteogene 
differentiatie alleen alveolair botherstel bevorderde. Gebaseerd op die resultaten 
werd geconcludeerd dat chondrogene differentiatie van BMSCs, voorafgaand aan 
implantatie, een bruikbare strategie vormt voor het regenereren van alveolair bot en 
parodontaal ligament, in het gebruikte rattenmodel.
samenvatting, afsluitende opmerkingen, en toekomstperspectief
143
7
3  Kan parodontale regeneratie met gebruik van chondrogene differentiatie 
verbeterd worden met behulp van een gelatinespons, die relatief sneller afbreekt 
en minder immunogeen is dan de eerder gebruikte PLGA/PCL drager?
De voorafgaande studie in hoofdstuk 3 liet zien dat chondrogene differentiatie 
van BMSCs voorafgaand aan implantatie leidde tot parodontale regeneratie. De 
langzame afbraak en zure degradatieproducten van de poly(melk-glycolzuur)/
poly(ε-caprolacton) (PLGA/PCL) drager zorgde echter voor beperkingen. Daarom 
werd in hoofdstuk 4, een gelatinespons gebruikt, die sneller afbreekt en minder 
immunogeen is. De efficientie van parodontale regeneratie werd onderzocht na het 
implanteren van PDL cellen of BMSC met chondrogene differentiatie. BMSCs werden 
verkregen uit Fischer ratten en gezaaid op PLGA/PCL dragers en gelatinesponsjes, 
en daarna voorgekweekt in een chondrogeen differentiatiemedium. Daarnaast 
werden PDL cellen in gelatineponsjes gebruikt. Vervolgens werden deze constructen 
gedurende 6 weken geïmplanteerd in parodontale defecten die gemaakt waren in 
Fischer ratten. Parodontale regeneratie werd vervolgens geëvalueerd door middel 
van histomorphometrische analysen. De chondrogene differentiatie aanpak met de 
gelatinespons liet een duidelijkere regeneratie zien van alveolair bot, parodontaal 
ligament en vascularisatie vergeleken met de PLGA/PCL drager. Het implanteren 
van PDL cellen leidde tot een vergelijkbare oppervlakte van nieuw bot, echter met 
een lagere hoogte van het alveolaire bot. In conclusie kan gezegd worden dat 
gelatinespons gebruikt kan worden als een geschikte celdrager voor het induceren 
van chondrogene differentiatie van BMSCs in vitro, en daarmee voor het verbeteren 
van parodontale regeneratie.
4  Kan het aantrekken van cellen naar een gelatinespons een alternatief vormen voor 
parodontale regeneratie, in vergelijking met celimplantatie?
Chemo-attractanten, zoals SDF-1α, kunnen wellicht bruikbaar zijn voor parodontale 
regeneratie. Deze stoffen kunnen stamcellen van de patiënt zelf aantrekken, en 
zo reparatie stimuleren. In hoofdstuk 5, werd een chemo-attractief construct voor 
parodontaal herstel gemaakt, waarbij SDF-1α werd gebruikt. De doelmatigheid 
werd geëvalueerd in vivo. SDF-1α werd daarvoor geladen op een gelatinespons, en 
eerst in vitro getest ten aanzien van SDF-1α vrijgave. Vervolgens werden de SDF-
1α constructen geïmplanteerd in een parodontaal defect in ratten gedurende 1 en 
6 weken, waarbij zowel niet-geladen materialen als lege defecten dienden als de 
controles. De doelmatigheid van de regeneratie werd daarna geëevalueerd met 
behulp van micro-CT, histologie en histomorfometrische analyses. In vitro resultaten 
lieten slechts een beperkte SDF-1α vrijgave zien tot aan 35 dagen. In contrast, zorgden 
de SDF-1α constructen in vivo toch voor een significant verbeterde regeneratie van 
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de parodontale defecten, wanneer er gekeken werd naar de alveolaire bot hoogte, 
hoeveelheid nieuw gevormd bot, en functionele lengte van het ligament. Tenslotte 
verlaagden de SDF-1α constructen de ontstekingsreactie op week 6.
In dit hoofdstuk verbeterden de chemo-attractieve constructen significant de 
parodontale regeneratie. Deze constructen zouden dus verder ontwikkeld moeten 
worden voor klinisch gebruik in het veld van de parodontologie.
2 Afsluitende opmerkingen en toekomstperspectief
In dit proefschrift werd geprobeerd om weefselregeneratie strategieën te ontwikkelen 
op basis van cellen en ten bate van parodontale regeneratie. De resultaten bevestigden 
dat zulke strategieën veelbelovend zijn en potentieel hebben voor verdere ontwikkeling 
tot echte toepassingen op het gebied van de klinische parodontologie. Als eerste 
werden er in hoofdstuk 2 humane dentale mesenchymale (DM) cellen die verkregen 
waren uit de pulpa, en varkens dentale epitheliale (DE) cellen, samen ingezaaid op 
driedimensionale PLGA/PCL dragers, om zo het tandorgaan te regenereren (inclusief 
de parodontale weefsels). De resultaten lieten zien dat de ultrasoon behandelde 
PLGA/PCL dragers konden zorgen voor evidente cel klustering, met verhoogde 
DM-DE cel-cel interactie, hetgeen noodzakelijk is voor de tandontwikkeling. Het 
materiaal werd dus geschikt geacht voor dentale weefselregeneratie, en dit resultaat 
ondersteunde verdere toekomstige in vivo evaluatie van een dergelijke strategie. Als 
tweede, werd er in hoofdstuk 3 een chondrogene differentiatie aanpak gekozen voor 
BMSCs tijdens parodontale regeneratie. Daarbij werden dezelfde dragers gebruikt als 
in hoofdstuk 2. De resultaten lieten zien dat een dergelijke aanpak de regeneratie van 
alveolair bot en ligamentweefsel ondersteunt, in een 3-zijdig parodontaal botdefect in 
de rat. De langzame afbraak, en de zure afbraakproducten van de PLGA/PCL dragers 
kon echter potentieel interfereren met de weefselvorming. Daarom werd in hoofdstuk 
4 een gelatine spons gebruikt, die een snellere afbraak en lagere immunogeniciteit liet 
zien, om parodontaal herstel via de chondrogene differentiatie route voor BMSCs te 
bewerkstelligen. De resultaten bevestigden een verhoogde regeneratie, en maakten 
daarmee duidelijk dat vertaling naar de kliniek voor een dergelijke aanpak mogelijk 
moet zijn. Als derde werd in hoofdstuk 5 een aanpak geïntroduceerd waarbij cellen van 
de gastheer zelf aangetrokken werden, om zo parodontale regeneratie te verkrijgen. 
Een gelatinespons, geladen met de factor SDF-1α, verbeterde de regeneratie 
significant wanneer de hoogte van het alveolaire bot, de oppervlakte van het nieuw 
gevormd bot, en de functionele lengte van het ligament beschouwd werden, in 
vergelijking met ongeladen dragers en lege defecten als controle groepen.
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Desondanks dienen verschillende vragen nog beantwoord te worden, voordat een 
dergelijke technologie inderdaad kan worden geïmplementeerd. Ten eerste is het 
belangrijk te onderkennen dat alle conclusies in dit proefschrift gebaseerd zijn op 
celkweek- en dierexperimenten, die natuurlijk niet altijd direct vertaald kunnen worden 
naar de humane situatie. In deze thesis, werd een kunstmatig chirurgisch, aan 3 kanten 
omsloten, botdefect gecreëerd bij de eerste molaar in de bovenkaak van een rat. In dit 
model werd het regeneratieve effect van verschillende cellen en weefselregeneratie 
aanpakken beschouwd. Het natuurlijk parodontium wordt echter chronisch 
blootgesteld aan een microbiologische omgeving, en de defecten die hierbij ontstaan 
zijn daardoor altijd verschillend van vorm en mate van beschadiging aan de anatomie 
(horizontale of verticale botdefecten; een- twee-, of driezijdig; furcatiedefecten, 
etc.)[5]. Het blijft onbekend hoe het ontbreken van een microbiologische aanleiding 
van het defect de uitkomsten van de huidige studies heeft bepaald. Er zijn wel 
muizenmodellen beschikbaar waarin parodontitis geïnitieerd wordt door middel van 
een microbiologische belasting, maar ook die modellen zijn nog steeds niet precies 
hetzelfde als de oorzaak en het verloop van parodontale ziekte bij de mens. Daarom 
is het belangrijk dat er nieuwe aanpakken gezocht worden (bv. lab-on-a chip, high-
throughput technieken, etc.) of dat er diermodellen ontworpen worden die beter lijken 
op de oorzaak en het verloop bij mensen. 
Vervolgens is het belangrijk voor succesvolle cel-gebaseerde aanpakken, om 
strategieën te ontwikkelen waarbij geïmplanteerde cellen kunnen overleven. Alhoewel 
het beschreven is dat BMSCs na implantatie in een parodontaal defect kunnen 
overleven en de regeneratie kunnen bevorderen[6], spreekt een meer recente studie 
deze bevinding tegen[7]. Dit experiment volgde getransplanteerde GFP-positieve PDL 
cellen in kritisch schedeldak defect in de rat, en toonde aan dat de aantallen cellen 
afnamen na 4 weken, en dat er na 10 weken zelfs geen of maar enkele positieve cellen 
detecteerbaar waren. Dit zou betekenen dat getransplanteerde cellen verdwijnen 
na implantatie. Een reden voor dit verdwijnen zou kunnen liggen aan het gebrek aan 
vascularisatie van het geïmplanteerde construct. Een mogelijke aanpak is dus het 
stimuleren van vascularisatie door co-kweek met angiogene cellen, of het toevoegen 
van angiogene factoren. Een andere methode is de hierin gebruikte chondrogene 
differentiatie aanpak, omdat het bekend is dat chondrocyten in staat zijn te overleven 
met slechts een beperkte beschikbaarheid van voedingsstoffen en zuurstof, en ze 
bovendien VEGF uitscheiden om bloedvat ingroei te stimuleren. 
Een hoge celdichtheid is cruciaal voor het vormen van kraakbeen in vitro. Door de 
beperkte beschikbaarheid van cellen en de langdurige in vitro celconditionering (5 
weken in deze studies), lijkt een klinische vertaling van de chondrogene differentiatie 
aanpak echter ook nog uitdagend, wanneer autologe cellen gebruikt zouden worden. 
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Het gebruik van makkelijker beschikbare stamceltypes zou onderzocht moeten 
worden, zoals mesenchymale stamcellen verkregen uit vet of gingiva. Bovendien laat 
een recente publicatie, waarbij een cel-vrije extracellulaire matrix gebruikt werd voor 
chondrogene differentiatie, wellicht een geschiktere methode zien waarbij de huidige 
beperkingen overwonnen zouden kunnen worden.[8]. Er kunnen bijvoorbeeld dragers 
worden gebruikt, die verschillende biologische signaalstoffen laten vrijkomen op het 
juiste moment. Deze signaalstofjes zorgen er dan voor dat cellen van de ontvanger 
zelf aanleiding geven tot endochondrale botvorming en uiteindelijk parodontaal 
herstel, zelfs zonder dat er exogene cellen geïmplanteerd zijn. Belangrijker nog is 
om het onderliggende mechanisme betrokken bij in vitro chondrogene differentiatie 
en parodontale regeneratie na implantatie van kraakbeenconstructen beter te 
onderzoeken. Alleen wanneer de cellulaire en moleculaire gebeurtenissen die 
betrokken zijn bij deze processen geheel opgehelderd zijn, kan een betrouwbare 
chondrogene differentiatie aanpak verder vereenvoudigd worden, en uiteindelijk 
doelmatig klinisch toepasbaar worden.
Alhoewel het aantrekken van cellen leidde tot een verbeterde parodontale regeneratie 
in de huidige studie, was de in vitro vrijgave van SDF-1α vanaf de gelatinespons 
nog suboptimaal[9]. Extensief onderzoek is nodig naar andere SDF-1α dragers (zoals 
polymere dragermaterialen), of zelfs naar het gebruik van gentransductie om SDF-1α 
expressie te verhogen. Het ontwerp van de dragers moet daarbij aangepast worden 
om SDF-1α vrijgave te controleren in de tijd en plek, d.w.z. er moet bepaald worden 
hoe de volgorde van de vrijgave dient te zijn op verschillende anatomische locaties 
(oppervlak van de wortel, alveolaire bot, en de ruimte daartussen in), op een manier 
die het natuurlijke regeneratieve proces van de verschillende parodontale weefsels 
weerspiegelt.
In samenvatting, kan gezegd worden dat de vooruitgang in kennis over celbiologie, 
materiaalkunde, en biomoleculen uitdagende mogelijkheden bieden voor klinische 
translatie van nieuwe tandheelkundige weefselregeneratie strategieën. Echter, 
voordat een techniek voor algehele parodontale regeneratie geïntroduceerd kan 
worden in parodontale klinieken zijn er nog vele uitdagingen die vervolgstudies 
noodzakelijk maken. Daarbij moet gefocusseerd worden op het ontwerp van 
dragermaterialen die de cel-cel interactie tussen DM-DE kunnen verbeteren, op het 
optimaliseren van de chondrogene differentiatie aanpak, op het versnellen van het 
in vitro celconditioneringsproces, op het controleren van SDF-1α vrijgave op het 
juiste moment en de juiste plek, op het bestuderen van de onderliggende cellulaire 
en moleculaire mechanismen betrokken bij het parodontale regeneratie proces, 
en tenslotte op het ontwikkelen van alternatieve modellen die gelijkend zijn aan 
parodontale ziekte bij de mens.
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